<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0420</journal-id>
<journal-title><![CDATA[Revista Uruguaya de Cardiología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Urug.Cardiol.]]></abbrev-journal-title>
<issn>1688-0420</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Uruguaya de Cardiología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-04202013000100009</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Insuficiencia valvular pulmonar en el posoperatorio alejado de tetralogía de Fallot: Aporte del ecocardiograma transtorácico convencional para la toma de decisiones]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Guzzo de León]]></surname>
<given-names><![CDATA[Daniel Felipe]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Universidad de la República UdelaR Facultad de Medicina Cardiología Pediátrica]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2013</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<numero>1</numero>
<fpage>42</fpage>
<lpage>56</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-04202013000100009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-04202013000100009&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-04202013000100009&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen La insuficiencia valvular pulmonar constituye uno de los principales problemas en el posoperatorio alejado de tetralogía de Fallot, siendo su incidencia muy frecuente y dependiente de múltiples aspectos. En este trabajo se efectúa una revisión relacionada con la utilidad de la ecocardiografía transtorácica convencional como instrumento para la evaluación de los pacientes con insuficiencia valvular pulmonar en el posoperatorio alejado de la tetralogía de Fallot. Se exponen los principales conceptos fisiopatológicos de esta entidad y, en función de ellos, se presentan los parámetros ecocardiográficos más relevantes a tener en cuenta en la valoración de estos pacientes. Finalmente se consideran las pautas y la oportunidad para el reemplazo valvular pulmonar.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Summary Pulmonary valve regurgitation is one of the main problems in the late post-op of Tetrallogy of Fallot, having a great incidence and depending on many aspects . In these paper a review is done considering the usefulness of conventional transtoracic ecocardiography as a tool to evaluate patients with pulmonary regurgitation.in the late post-op of Tetralogy of Fallot. Main physiopathologic concepts about these entity are presented, and as a function of that, the most important ecocardiographic parameters to be considered evaluating these patients are also described. Finally guidelines on the opportunity for pulmonary valve replacement are considered.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[TETRALOGíA DE FALLOT-cirugía]]></kwd>
<kwd lng="es"><![CDATA[INSUFICIENCIA DE LA VÁLVULA PULMONAR]]></kwd>
<kwd lng="es"><![CDATA[CIRUGíA TORÁCICA-métodos]]></kwd>
<kwd lng="es"><![CDATA[PROCEDIMIENTOS QUIRÚRGICOS OPERATORIOS -métodos]]></kwd>
<kwd lng="es"><![CDATA[ECOCARDIOGRAFíA]]></kwd>
<kwd lng="es"><![CDATA[ECOCARDIOGRAFíA TRIDIMENSIONAL]]></kwd>
<kwd lng="en"><![CDATA[TETRALOGY OF FALLOT-surgery]]></kwd>
<kwd lng="en"><![CDATA[PULMONARY VALVE INSUFICIENCY]]></kwd>
<kwd lng="en"><![CDATA[THORACIC SURGERY-methods]]></kwd>
<kwd lng="en"><![CDATA[SURGICAL PROCEDURES, OPERATIVE-methods]]></kwd>
<kwd lng="en"><![CDATA[ECHOCARDIOGRAPHY]]></kwd>
<kwd lng="en"><![CDATA[TRI-DIMENSIONAL ECHOCARDIOGRAPHY]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[            <basefont size="3"> <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"><b>Art&iacute;culo de revisi&oacute;n&nbsp;</b>Insuficiencia valvular pulmonar en el posoperatorio alejado de tetralog&iacute;a  de Fallot&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> Daniel Felipe Guzzo de Le&oacute;n&nbsp; </font></p>               <p align="left"><b> <font face="Verdana" size="4">Insuficiencia valvular pulmonar en el posoperatorio alejado de tetralog&iacute;a  de Fallot.&nbsp; </font></b></p>               <p align="left"><b><font face="Verdana"> Aporte del ecocardiograma transtor&aacute;cico convencional para la toma de decisiones&nbsp; </font></b></p>               <p align="left"><font face="Verdana" size="2"> Dr. Daniel Felipe Guzzo de Le&oacute;n </font><sup> <font color="#d62437" face="Verdana" size="2"><a href="#1.">1</a></font><font face="Verdana" size="2">&nbsp;</font></sup><font face="Verdana" size="2"> </font></p>               <p align="left"><font face="Verdana" size="2"><a name="1."></a>1. Coordinador del Comit&eacute; Docente de Cardiolog&iacute;a Pedi&aacute;trica. Facultad de  Medicina. Universidad de la Rep&uacute;blica. Montevideo, Uruguay.    <br>           Correspondencia:  Coronel Alegre 1168/101. CP: 11300. Montevideo, Uruguay.     <br>           Correo electr&oacute;nico: </font><font color="#1f1a17" face="Verdana" size="2">  <a href="mailto:guzzo@adinet.com.uy">guzzo@adinet.com.uy</a></font><font face="Verdana" size="2">    <br>           Recibido diciembre 11, 2012; aceptado febrero 19, 2013&nbsp; </font></p>               ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>Resumen&nbsp;</b> </font></p>               <p align="left"><font face="Verdana" size="2"> La insuficiencia valvular pulmonar constituye uno de los principales problemas  en el posoperatorio alejado de tetralog&iacute;a de Fallot, siendo su incidencia  muy frecuente y dependiente de m&uacute;ltiples aspectos. En este trabajo se efect&uacute;a  una revisi&oacute;n relacionada con la utilidad de la ecocardiograf&iacute;a transtor&aacute;cica  convencional como instrumento para la evaluaci&oacute;n de los pacientes con insuficiencia  valvular pulmonar en el posoperatorio alejado de la tetralog&iacute;a de Fallot.  Se exponen los principales conceptos fisiopatol&oacute;gicos de esta entidad y,  en funci&oacute;n de ellos, se presentan los par&aacute;metros ecocardiogr&aacute;ficos m&aacute;s  relevantes a tener en cuenta en la valoraci&oacute;n de estos pacientes. Finalmente  se consideran las pautas y la oportunidad para el reemplazo valvular pulmonar.&nbsp; </font></p>               <p align="left"> <font face="Verdana" size="2"><b>Palabras clave:    <br>           </b>&nbsp;&nbsp;&nbsp;&nbsp;TETRALOG&iacute;A DE FALLOT-cirug&iacute;a    <br>           &nbsp;&nbsp;&nbsp;&nbsp;INSUFICIENCIA DE LA V&Aacute;LVULA  PULMONAR    <br>           &nbsp;&nbsp;&nbsp;&nbsp;CIRUG&iacute;A TOR&Aacute;CICA-m&eacute;todos    <br>           &nbsp;&nbsp;&nbsp;&nbsp;PROCEDIMIENTOS QUIR&Uacute;RGICOS OPERATORIOS -m&eacute;todos    <br>           &nbsp;&nbsp;&nbsp;&nbsp;ECOCARDIOGRAF&iacute;A    <br>           &nbsp;&nbsp;&nbsp;&nbsp;ECOCARDIOGRAF&iacute;A  TRIDIMENSIONAL&nbsp; </font></p>          <font face="Verdana" size="2">              <br>           </font>               ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> <b>Summary&nbsp;</b> </font></p>               <p align="left"><font face="Verdana" size="2"> Pulmonary valve regurgitation is one of the main problems in the late post-op  of Tetrallogy of Fallot, having a great incidence and depending on many  aspects . In these paper a review is done considering the usefulness of  conventional transtoracic ecocardiography as a tool to evaluate patients  with pulmonary regurgitation.in the late post-op of Tetralogy of Fallot.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> Main physiopathologic concepts about these entity are presented, and as  a function of that, the most important ecocardiographic parameters to be  considered evaluating these patients are also described. Finally guidelines  on the opportunity for pulmonary valve replacement are considered.&nbsp; </font></p>               <p align="left"> <font face="Verdana" size="2"><b>Key words:</b>&nbsp;    <br>           &nbsp;&nbsp;&nbsp;TETRALOGY OF FALLOT-surgery    <br>           &nbsp;&nbsp;&nbsp;&nbsp;PULMONARY VALVE INSUFICIENCY    <br>           &nbsp;&nbsp;&nbsp;&nbsp;THORACIC   SURGERY-methods    <br>           &nbsp;&nbsp;&nbsp;&nbsp;SURGICAL PROCEDURES, OPERATIVE-methods    <br>           &nbsp;&nbsp;&nbsp;&nbsp;ECHOCARDIOGRAPHY    <br>           &nbsp;&nbsp;&nbsp;&nbsp;TRI-DIMENSIONAL   ECHOCARDIOGRAPHY&nbsp; </font></p>           <font face="Verdana" size="2">               ]]></body>
<body><![CDATA[<br>           </font>               <p align="left"><font face="Verdana" size="2"> <b>Introducci&oacute;n&nbsp;</b> </font></p>               <p align="left"><font face="Verdana" size="2"> Una proporci&oacute;n cada vez mayor de estudios, tanto cl&iacute;nicos como de investigaci&oacute;n  b&aacute;sica, ponen en evidencia y jerarquizan la importancia del conocimiento  fisiopatol&oacute;gico del ventr&iacute;culo derecho (VD) y de la v&aacute;lvula pulmonar en  el funcionamiento del coraz&oacute;n normal y en los corazones cong&eacute;nitamente  malformados.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> Por mucho tiempo se consider&oacute; como un hallazgo habitual y poco relevante  que, en el &nbsp;posoperatorio de la cirug&iacute;a correctiva de la tetralog&iacute;a de  Fallot, se documentase la presencia de incompetencia valvular pulmonar.  Sin embargo, actualmente se sabe que en realidad la insuficiencia valvular  pulmonar (IP) cr&oacute;nica conduce a dilataci&oacute;n y disfunci&oacute;n ventricular derecha,  disminuci&oacute;n de la capacidad para el ejercicio y riesgo de alteraciones  del ritmo card&iacute;aco y muerte s&uacute;bita</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#1">1</a></font><font face="Verdana" size="2">-</font><font color="#1f1a17" face="Verdana" size="2"><a href="#6">6</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".1"></a><a name=".2"></a><a name=".3"></a><a name=".4"></a><a name=".5"></a><a name=".6"></a>. Ya el grupo de Kirklin, en 1984,  hab&iacute;a demostrado que el 90% de los pacientes con insuficiencia nativa de  la v&aacute;lvula pulmonar estaba libre de s&iacute;ntomas de insuficiencia card&iacute;aca  derecha a los 25 a&ntilde;os de edad, pero que a los 50 a&ntilde;os de edad menos del  50% lo estaba</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#7">7</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.<a name=".7"></a>&nbsp; </font></p>                <p><font face="Verdana" size="2">Mientras el VD mantiene conservada su funci&oacute;n sist&oacute;lica, la IP tiene una  progresi&oacute;n cl&iacute;nica solapada y una larga fase compensada sin s&iacute;ntomas cl&iacute;nicos</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#1">1</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.  Los s&iacute;ntomas cl&iacute;nicos son de aparici&oacute;n tard&iacute;a y, cuando aparecen, habitualmente  ya existe disfunci&oacute;n sist&oacute;lica del VD y/o del ventr&iacute;culo izquierdo (VI)  y el da&ntilde;o puede ser irreversible</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#2">2</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#3">3</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#8">8</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".8"></a>. Adem&aacute;s existe una estrecha correlaci&oacute;n  entre disfunci&oacute;n de uno y otro ventr&iacute;culo, lo que sugiere una interacci&oacute;n  ventr&iacute;culo-ventricular desfavorable en este tipo de pacientes</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#8">8</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#9">9</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".9"></a>. Por  todas estas razones, se requieren par&aacute;metros que permitan detectar tempranamente  estos problemas y determinar la oportunidad del reemplazo valvular pulmonar.&nbsp; </font></p>           <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"> Se admite que la resonancia nuclear magn&eacute;tica (RNM) es la t&eacute;cnica de elecci&oacute;n  para la cuantificaci&oacute;n de IP, as&iacute; como para la evaluaci&oacute;n del tama&ntilde;o del  VD y su funci&oacute;n sist&oacute;lica</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#10">10</a></font><font face="Verdana" size="2">-</font><font color="#1f1a17" face="Verdana" size="2"><a href="#14">14</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".10"></a><a name=".11"></a><a name=".12"></a><a name=".13"></a><a name=".14"></a>; sin embargo, el ecocardiograma transtor&aacute;cico  (ETT), por su amplia disponibilidad, tiene su lugar en la valoraci&oacute;n inicial  de los pacientes para su seguimiento, para seleccionar cu&aacute;les de estos  pacientes requerir&aacute;n una RNM y para determinar la oportunidad de su realizaci&oacute;n.  Debido a su disponibilidad todav&iacute;a limitada en nuestras latitudes, no encararemos  aqu&iacute; el aporte de t&eacute;cnicas como la ecocardiograf&iacute;a tridimensional y otras  t&eacute;cnicas de desarrollo relativamente reciente como <i>strain,</i> <i>strain rate  </i>y<i> speckle tracking.</i> El cometido de esta revisi&oacute;n se centra en el aporte  del ETT y de las t&eacute;cnicas Doppler, de amplia disponibilidad en la pr&aacute;ctica  cl&iacute;nica de rutina.&nbsp; </font></p>          <font face="Verdana" size="2">              <br>           </font>               <p align="left"><font face="Verdana" size="2"> <b>Fisiopatolog&iacute;a de la insuficiencia valvular pulmonar&nbsp;</b> </font></p>               <p align="left"><font face="Verdana" size="2"> El primer punto a tener en cuenta es que no son extrapolables para la v&aacute;lvula  pulmonar los conceptos aprendidos para la insuficiencia valvular a&oacute;rtica.  El lecho vascular pulmonar es de baja resistencia y est&aacute; ubicado pr&oacute;ximo  al coraz&oacute;n. En cambio, el lecho vascular sist&eacute;mico es de alta resistencia  y se ubica lejos del ventr&iacute;culo izquierdo (VI)</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#1">1</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. Este hecho es relevante  porque de alguna manera, la baja resistencia del lecho vascular pulmonar  y su proximidad al VD genera un efecto &ldquo;v&aacute;lvula s&iacute;mil&rdquo; para el gasto pulmonar</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#15">15</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">  que limita la magnitud de la regurgitaci&oacute;n valvular pulmonar. Puede decirse  que la energ&iacute;a del VD es suficiente para vencer la baja resistencia del  lecho vascular pulmonar, ubicada cercanamente, y de ese modo contener cierta  proporci&oacute;n del retroceso del gasto pulmonar. Es por ello que pueden existir  IP importantes, con fracciones de regurgitaci&oacute;n inferiores a 40%. De hecho,  una IP &ldquo;libre&rdquo; se asocia precisamente con fracciones de regurgitaci&oacute;n en  torno a 40% (entre 25% y 65%)</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#15">15</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".15"></a>. Otros factores tambi&eacute;n inciden en la  magnitud de la IP como, por ejemplo, la presencia de parches transanulares  amplios o estenosis pulmonar distal residual</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#16">16</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.<a name=".16"></a> </font></p>               <p align="left"><font face="Verdana" size="2"> Se entiende por IP &ldquo;libre&rdquo; cuando no existe ning&uacute;n efecto de v&aacute;lvula que  limite la regurgitaci&oacute;n</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#15">15</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. Se sabe adem&aacute;s (concepto aprendido de la circulaci&oacute;n  de Fontan) que la energ&iacute;a del VI es suficiente para mantener la circulaci&oacute;n  pulmonar</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#1">1</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#15">15</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"> y finalmente debe comprenderse que la complacencia del lecho  vascular pulmonar por un lado y la del VD, por otro, juegan un rol determinante  en la magnitud de la IP</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#15">15</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>          <font face="Verdana" size="2">              ]]></body>
<body><![CDATA[<br>           </font>               <p align="left"><font face="Verdana" size="2"> <b>Aspectos de importancia que requieren evaluaci&oacute;n&nbsp;</b> </font></p>               <p align="left"><font face="Verdana" size="2"> Considerando los conceptos previamente expuestos resulta, entonces, de  importancia evaluar ecocardiogr&aacute;ficamente los siguientes aspectos: 1) funci&oacute;n  sist&oacute;lica y diast&oacute;lica del VI; 2) resistencias pulmonares; 3) funci&oacute;n sist&oacute;lica  y diast&oacute;lica del VD; 4) magnitud de la obstrucci&oacute;n pulmonar residual si  existe (infundibular, valvular y perif&eacute;rica); 5) magnitud de la IP; 6)  magnitud de la insuficiencia tricusp&iacute;dea (IT) si esta existe, y 7) remodelaci&oacute;n  de cavidades secundarias a la IP.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> El cometido de este trabajo se centra en los puntos segundo, tercero, quinto  y s&eacute;ptimo que exponemos a continuaci&oacute;n.&nbsp; </font></p>          <font face="Verdana" size="2">              <br>           </font>               <p align="left"><font face="Verdana" size="2"> <b>Estimaci&oacute;n de la resistencia vascular pulmonar&nbsp;</b> </font></p>               <p align="left"><font face="Verdana" size="2">Mucho se ha investigado acerca de par&aacute;metros o &iacute;ndices que brinden informaci&oacute;n de la presi&oacute;n arterial pulmonar, impedancia, capacitancia y resistencia del lecho vascular pulmonar</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#17">17</a></font><font face="Verdana" size="2">-</font><font color="#1f1a17" face="Verdana" size="2"><a href="#28">28</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".17"></a><a name=".18"></a><a name=".19"></a><a name=".20"></a><a name=".21"></a><a name=".22"></a><a name=".23"></a><a name=".24"></a><a name=".25"></a><a name=".26"></a><a name=".27"></a><a name=".28"></a>. Para la evaluaci&oacute;n de la resistencia  vascular pulmonar (RVP), la mayor&iacute;a de estos par&aacute;metros resultan consumidores  de tiempo o poco fiables y de hecho su uso ha sido sumamente restringido  en la pr&aacute;ctica. Sin embargo, la RVP constituye un par&aacute;metro relevante en  la fisiopatolog&iacute;a de varias afecciones cardiovasculares y condiciona significativamente  la conducta cl&iacute;nica. Es por ello que intentamos seleccionar alg&uacute;n indicador  que resulte &uacute;til para este cometido y de f&aacute;cil adquisici&oacute;n.&nbsp; </font></p>                <p><font face="Verdana" size="2">En la </font> <font color="#1f1a17" face="Verdana" size="2"> <a href="#figura_1">figura 1 A</a></font><font face="Verdana" size="2"> exponemos la f&oacute;rmula que expresa la RVP. Ella se relaciona  de modo directo con la diferencia de presiones entre arteria pulmonar y  aur&iacute;cula izquierda, y de modo inverso con el gasto pulmonar</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#19">19</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"> de acuerdo  a la ley de Ohm aplicada a los fluidos. Por eso la IT, que permite estimar  la presi&oacute;n sist&oacute;lica pulmonar, y el VTI del tracto de salida del ventr&iacute;culo  derecho (VTI-TSVD), que se relaciona con el gasto pulmonar, podr&iacute;an ser  usados como correlatos de diferencia de presiones y gasto pulmonar, respectivamente</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#19">19</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.  Si la RVP se modifica, se producen cambios en la velocidad m&aacute;xima de IT  y el VTI-TSVD en direcciones opuestas. Considerando estos hechos, Abbas  y colaboradores</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#18">18</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"> evaluaron el comportamiento de estos par&aacute;metros ecocardiogr&aacute;ficos,  de f&aacute;cil obtenci&oacute;n en los estudios de rutina, y los relacionaron con medidas  invasivas de RVP. La velocidad m&aacute;xima de la IT (Vm&aacute;xIT) en m/s y el VTI-TSVD  en cm se relacionaron del modo que se expone en la </font> <font color="#1f1a17" face="Verdana" size="2"> <a href="#figura_1">figura 1 B</a></font><font face="Verdana" size="2">. Los autores  demostraron que esta relaci&oacute;n se correlaciona adecuadamente con las medidas  invasivas de RVP (r = 0,929; IC: 0,87 a 0,96). Con la f&oacute;rmula corregida  (Vmax.IT/VTI del TSVD x 10 + 0,16, </font> <font color="#1f1a17" face="Verdana" size="2"> <a href="#figura_1">figura 1B</a></font><font face="Verdana" size="2">) se demuestran l&iacute;mites de  confianza satisfactorios. Cuando el punto de corte se estableci&oacute; en 0,2  se encontr&oacute; 94% de especificidad y 70% de sensibilidad para definir RVP  &gt; a 2 unidades Wood (UW) (rango normal = 0,75 a 1,87 UW).&nbsp;</font></p>         <p> <multicol gutter="18" cols="2"></multicol><font face="Verdana" size="2">&nbsp;<a name="figura_1"></a>&nbsp;<img style="width: 566px; height: 252px;" alt="" src="/img/revistas/ruc/v28n1/1a09f1.JPG">     <br>           </p>              </font><font face="Verdana" size="2">&nbsp; &nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; </font> <multicol gutter="18" cols="2"></multicol>     ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Supongamos, por ejemplo, la situaci&oacute;n de un paciente con hipertensi&oacute;n arterial  pulmonar (HAP) cuya Vmax.IT es 2,88 m/seg, lo que permite estimar un gradiente  entre VD y AD de 33 mmHg (</font><font color="#1f1a17" face="Verdana" size="2"><a href="#figura_2">figura 2</a></font><font face="Verdana" size="2">). Si el VTI-TSVD fuera igual a 9 cm,  la RVP ser&iacute;a 3,36 UW, es decir, 268,8 dinas/seg/cm<sup>-5</sup>(*).</font><font face="Century Schoolbook" size="2"><font face="Verdana"><sup>&nbsp;</sup></font><font face="Verdana" size="2"> </font> </font></p>               <p align="left"><font face="Verdana" size="2">(*) dina/seg/cm<sup>-5</sup> = UW x 80&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> <a name="figura_2"></a><img style="width: 566px; height: 389px;" alt="" src="/img/revistas/ruc/v28n1/1a09f2.JPG">    <br>           </font>           </p>                     <p align="left"><font face="Verdana" size="2">En cambio, otro paciente con la misma presi&oacute;n sist&oacute;lica arterial pulmonar,   pero con un VTI-TSVD de 17 cm, su RVP ser&iacute;a normal (1,85 UW = 148 dinas/seg/cm<sup>-5</sup>).&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> Los autores proponen el t&eacute;rmino &ldquo;presi&oacute;n pulmonar aumentada&rdquo; para referirse  al incremento de la presi&oacute;n arterial pulmonar sist&oacute;lica e &ldquo;hipertensi&oacute;n  pulmonar&rdquo; para aquellos pacientes que adem&aacute;s tienen aumentada la RVP.&nbsp; </font></p>        <font face="Verdana" size="2"><b>Funci&oacute;n sist&oacute;lica y diast&oacute;lica del ventr&iacute;culo derecho&nbsp;</b> </font>       <p align="left"><font face="Verdana" size="2"> La evaluaci&oacute;n funcional del VD sigue configurando un desaf&iacute;o por su compleja  morfolog&iacute;a. No existe un modelo geom&eacute;trico sencillo que permita calcular  su volumen mediante ecocardiograf&iacute;a bidimensional. La ecocardiograf&iacute;a tridimensional  puede jugar un rol importante al respecto, pero por el momento su uso no  est&aacute; disponible de modo generalizado. Adem&aacute;s, la gruesa trabeculaci&oacute;n del  VD dificulta la definici&oacute;n del endocardio y finalmente su posici&oacute;n anterior  hace complicada su visualizaci&oacute;n ecogr&aacute;fica</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#29">29</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".29"></a>. Por ello, cuando se eval&uacute;a  su morfolog&iacute;a por ecocardiograf&iacute;a bidimensional, es recomendable obtener  varios enfoques desde diferentes proyecciones</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#23">23</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. No obstante estas dificultades,  existen varios par&aacute;metros que permiten una estimaci&oacute;n satisfactoria de  la funci&oacute;n ventricular derecha mediante ETT.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> <b>1) Fracci&oacute;n de acortamiento del &aacute;rea del ventr&iacute;culo derecho&nbsp;</b> </font></p>               <p align="left"><font face="Verdana" size="2"> Este par&aacute;metro (</font><font color="#1f1a17" face="Verdana" size="2"><a href="#figura_3">figura 3</a></font><font face="Verdana" size="2">) mostr&oacute; excelente correlaci&oacute;n (r = 0,80; p &lt; 0,001)  con estimaciones de la fracci&oacute;n de eyecci&oacute;n del VD realizadas mediante  RNM</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#30">30</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".30"></a>.&nbsp; </font></p>               <p><font face="Verdana" size="2"><a name="figura_3"></a><img style="width: 566px; height: 305px;" alt="" src="/img/revistas/ruc/v28n1/1a09f3.JPG">    ]]></body>
<body><![CDATA[<br>        </font>        </p>                     <p align="left"><font face="Verdana" size="2">&nbsp;<b>2) Excursi&oacute;n sist&oacute;lica del anillo tricusp&iacute;deo&nbsp;</b> </font></p>               <p align="left"><font face="Verdana" size="2"> Como puede verse en la</font><font color="#1f1a17" face="Verdana" size="2"><a href="#figura_4"> figura 4</a></font><font face="Verdana" size="2">, este par&aacute;metro consiste en registrar en  modo M el desplazamiento longitudinal de la extremidad lateral del anillo  tricusp&iacute;deo. El valor normal es de 20 mm &plusmn; 2,8 mm. Desplazamientos menores  a 17 mm son altamente espec&iacute;ficos (aunque de baja sensibilidad)</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#31">31</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><sup><a name=".31"></a> </sup>para  detectar disfunci&oacute;n sist&oacute;lica del VD. Este par&aacute;metro ha demostrado buena  correlaci&oacute;n con estimaciones de la fracci&oacute;n de eyecci&oacute;n llevadas a cabo  mediante angiograf&iacute;a radioisot&oacute;pica</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#32">32</a></font><font face="Verdana" size="2">)<a name=".32"></a> </font> </sup><font face="Verdana" size="2">y tiene valor predictivo de supervivencia  en el contexto de HAP</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#33">33</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".33"></a>.&nbsp; </font></p>                <p><font face="Verdana" size="2"><a name="figura_4"></a><img style="width: 274px; height: 401px;" alt="" src="/img/revistas/ruc/v28n1/1a09f4.JPG">    <br>        </font>        </p>                  <p><font face="Verdana" size="2"><b>3) Doppler pulsado tisular del anillo tricusp&iacute;deo e &iacute;ndice de performance  mioc&aacute;rdico (&iacute;ndice de Tei)&nbsp;</b> </font></p>           <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"> El Doppler pulsado tisular se obtiene ubicando el volumen muestra en la  extremidad lateral del anillo tricusp&iacute;deo, como muestra la </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#figura_5">figura 5</a></font><font face="Verdana" size="2">. Se  obtiene el registro caracter&iacute;stico constituido por onda sist&oacute;lica (S&rsquo;)  y dos ondas diast&oacute;licas E&rsquo; y A&rsquo;, respectivamente.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="figura_5"></a><img style="width: 274px; height: 360px;" alt="" src="/img/revistas/ruc/v28n1/1a09f5.JPG">    <br>        </font>        </p>        <font face="Verdana" size="2">Para la evaluaci&oacute;n de la funci&oacute;n sist&oacute;lica del VD tiene importancia la determinaci&oacute;n de la velocidad de S&acute;. El valor normal de esta medida debe ser superior a 12 cm/seg. Un valor inferior a 10 cm/seg es indicador de disfunci&oacute;n sist&oacute;lica del VD</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#31">31</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font>       <p align="left"><font face="Verdana" size="2">Este registro permite, adem&aacute;s, obtener los par&aacute;metros necesarios para el  c&aacute;lculo del &iacute;ndice de Tei o &iacute;ndice de performance mioc&aacute;rdica</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#34">34</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".34"></a> mediante  Doppler tisular, a saber: tiempo de contracci&oacute;n isovolum&eacute;trica (TCIV);  tiempo de relajaci&oacute;n isovolum&eacute;trica (TRIV), y tiempo de eyecci&oacute;n (Ey), </font> <font color="#1f1a17" face="Verdana" size="2">  <a href="#figura_6">figuras 6</a></font><font face="Verdana" size="2"> y </font> <font color="#1f1a17" face="Verdana" size="2"> <a href="#figura_7">7</a></font><font face="Verdana" size="2">.&nbsp; </font></p>               ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"><a name="figura_6"></a><img style="width: 274px; height: 320px;" alt="" src="/img/revistas/ruc/v28n1/1a09f6.JPG">    <br>        </font>        </p>        <font face="Verdana" size="2">        <a name="figura_7"></a><img style="width: 566px; height: 291px;" alt="" src="/img/revistas/ruc/v28n1/1a09f7.JPG">    <br>           </font>               <p align="left"><font face="Verdana" size="2">&nbsp;El &iacute;ndice de Tei o &iacute;ndice de performance mioc&aacute;rdica</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#34">34</a></font><font face="Verdana" size="2">-</font><font color="#1f1a17" face="Verdana" size="2"><a href="#36">36</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".35"></a><a name=".36"></a> es un par&aacute;metro  de funci&oacute;n global (sist&oacute;lica y diast&oacute;lica). Su valor normal para el VD  debe ser menor de 0,28 &plusmn; 0,04, seg&uacute;n Jurcut y colaboradores</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#37">37</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".37"></a>. Sin embargo,  las gu&iacute;as de la Sociedad Americana de Ecocardiograf&iacute;a</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#38">38</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".38"></a> admiten otros  niveles de tolerancia considerando como l&iacute;mites m&aacute;ximos normales valores  de 0,40 para la estimaci&oacute;n del &iacute;ndice de Tei mediante Doppler pulsado y  hasta 0,55 utilizando Doppler pulsado tisular. Si tenemos en cuenta los  estudios de Grignola, Gin&eacute;s y Guzzo</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#39">39</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#40">40</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".39"></a><a name=".40"></a> realizados en el Departamento  de Fisiolog&iacute;a de la Facultad de Medicina de Montevideo en corderos anestesiados,  estos valores resultan demasiado prolongados. En efecto, los trabajos de  Grignola y colaboradores</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#39">39</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#40">40</a></font><font face="Verdana" size="2">) </font> </sup><font face="Verdana" size="2">demuestran que pr&aacute;cticamente no existen  per&iacute;odos isom&eacute;tricos para el VD. Por lo tanto, necesariamente los &iacute;ndices  de Tei normales tienen que ser muy cortos y tendientes a valores pr&oacute;ximos  a 0,00. De hecho, en estos trabajos realizados con corderos anestesiados,  todos los &iacute;ndices de Tei estimados resultaron en torno a 0,06 &plusmn; 0,03 pero  aumentan significativamente al elevar la poscarga de modo agudo, como,  por ejemplo, en el contexto de hipertensi&oacute;n arterial pulmonar aguda. En  estas circunstancias se logran valores de 0,31 &plusmn; 0,06. Las diferencias  encontradas con las publicaciones mencionadas previamente</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#37">37</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#38">38</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"> podr&iacute;an  deberse a las condiciones de experimentaci&oacute;n (corderos anestesiados y a  t&oacute;rax abierto), pero el punto podr&iacute;a merecer una revisi&oacute;n antes de asumir  como &ldquo;normales&rdquo; los valores se&ntilde;alados precedentemente.&nbsp; </font></p>                <p><font face="Verdana" size="2">El &iacute;ndice de Tei tambi&eacute;n puede estimarse mediante Doppler convencional,  pero tiene el inconveniente respecto del Doppler tisular de que no todas  las mediciones necesarias pueden obtenerse en un mismo ciclo card&iacute;aco.  En efecto, utilizando Doppler convencional deben efectuarse dos medidas  separadas en diferentes ciclos a saber: 1) el registro del flujo diast&oacute;lico  de la v&aacute;lvula tric&uacute;spide, y 2) el registro del flujo sist&oacute;lico en el tracto  de salida del VD (ver esquema de la </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#figura_7">figura 7</a></font><font face="Verdana" size="2">).&nbsp; </font></p>           <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"> El Doppler pulsado tisular del anillo tricusp&iacute;deo tambi&eacute;n brinda informaci&oacute;n  acerca de la funci&oacute;n diast&oacute;lica del VD. Normalmente, en reposo, la onda  E&rsquo; del Doppler tisular (</font><font color="#1f1a17" face="Verdana" size="2"><a href="#figura_5">figuras 5</a></font><font face="Verdana" size="2"> y </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#figura_7">7</a></font><font face="Verdana" size="2">) alcanza 14,5 +/- 3,5 cm/seg. Su  relaci&oacute;n respecto de la velocidad de la onda E del flujo diast&oacute;lico tricusp&iacute;deo  (E/E&rsquo;) es un par&aacute;metro indicador de disfunci&oacute;n diast&oacute;lica del VD. Una relaci&oacute;n  E/E&rsquo; &gt; 6 indica disfunci&oacute;n diast&oacute;lica del ventr&iacute;culo derecho</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#37">37</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> <b>4) Aceleraci&oacute;n isovolum&eacute;trica del miocardio&nbsp;</b> </font></p>               <p align="left"><font face="Verdana" size="2"> En el registro Doppler tisular de la porci&oacute;n lateral del anillo tricusp&iacute;deo  durante el per&iacute;odo isom&eacute;trico, precediendo a la onda S&rsquo;, se inscribe una  onda que comienza antes del pico de la onda R del electrocardiograma (</font><font color="#1f1a17" face="Verdana" size="2"><a href="#figura_8">figura  8</a></font><font face="Verdana" size="2">). La relaci&oacute;n de la velocidad pico de esta onda en m/seg dividido por  el intervalo de tiempo en segundos entre el comienzo de esta onda y su  velocidad pico ha demostrado ser un &iacute;ndice de contractilidad del VD, independiente  de condiciones de pre y poscarga</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#41">41</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".41"></a>. Su valor normal debe ser mayor de  1,2 m/s2</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#42">42</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".42"></a>. </font></p>           <font face="Verdana" size="2">           <a name="figura_8"></a><img style="width: 349px; height: 445px;" alt="" src="/img/revistas/ruc/v28n1/1a09f8.JPG">    <br>           </font>               <p align="left"><font face="Verdana" size="2"> <b>Magnitud de la insuficiencia pulmonar residual&nbsp;</b> </font></p>               ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> La RNM es el patr&oacute;n de referencia para determinar la fracci&oacute;n de regurgitaci&oacute;n  pulmonar</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#9">9</a></font><font face="Verdana" size="2">-</font><font color="#1f1a17" face="Verdana" size="2"><a href="#13">13</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">; sin embargo, el ecocardiograma convencional hace su aporte  para la evaluaci&oacute;n inicial del paciente y para seleccionar aquellos que  requerir&aacute;n una RNM.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> Desde 1989 se conoce el m&eacute;todo emp&iacute;rico de Nanda</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#43">43</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".43"></a>, basado principalmente  en la magnitud del ancho del jet color de la regurgitaci&oacute;n, pero tambi&eacute;n  considerando hasta qu&eacute; punto se introduc&iacute;a en el VD. En esencia se consideraba  que si el ancho del jet color era mayor a 50% del ancho del tracto de salida  del ventr&iacute;culo derecho (TSVD), entonces la regurgitaci&oacute;n era significativa  (</font><font color="#1f1a17" face="Verdana" size="2"><a href="/img/revistas/ruc/v28n1/1a09f9.JPG">figura 9 A</a></font><font face="Verdana" size="2">).&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> M&aacute;s recientemente, Li, Davluoros, Kilner y colaboradores</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#44">44</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".44"></a> demostraron  que en adultos, un ancho del jet color de la regurgitaci&oacute;n pulmonar de  0,98 cm correlaciona con fracciones de regurgitaci&oacute;n de 24,5% en la RNM,  con una sensibilidad y especificidad de 92% y 74%, respectivamente ( r  = 0,72, p = 0,001).&nbsp; </font></p>            <font face="Verdana" size="2">Una forma emp&iacute;rica de evaluar la magnitud de la IP lo constituye el registro  de flujo diast&oacute;lico reverso en arteria pulmonar distal. Se supone que esto  implica regurgitaci&oacute;n pulmonar significativa.&nbsp; </font> <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"> El m&eacute;todo volum&eacute;trico permite calcular el volumen regurgitante y estimar  la fracci&oacute;n de regurgitaci&oacute;n mediante las f&oacute;rmulas expuestas en la </font><font color="#1f1a17" face="Verdana" size="2"> <a href="/img/revistas/ruc/v28n1/1a09f9.JPG">figura  9 B</a></font><font face="Verdana" size="2">. De todos modos, cabe se&ntilde;alar que algunos estudios indican que resulta  m&aacute;s confiable la estimaci&oacute;n del volumen de regurgitaci&oacute;n que la fracci&oacute;n  de regurgitaci&oacute;n para evaluar la sobrecarga volum&eacute;trica del VD</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#9">9</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>        <font face="Verdana" size="2">Li y colaboradores</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#44">44</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"> tambi&eacute;n demostraron que la relaci&oacute;n del tiempo de  regurgitaci&oacute;n pulmonar respecto de la duraci&oacute;n de la di&aacute;stole (&iacute;ndice de  regurgitaci&oacute;n pulmonar o IR) constitu&iacute;a un par&aacute;metro estimativo de la severidad  de la regurgitaci&oacute;n (</font><font color="#1f1a17" face="Verdana" size="2"><a href="#figura_10">figura 10</a></font><font face="Verdana" size="2">). Un coeficiente inferior a 0,77 correlaciona  con fracciones de regurgitaci&oacute;n superiores a 24,5% obtenidas mediante RNM,  con una sensibilidad de 100%, especificidad de 84,6%, y valor predictivo  de 95%.     <br>     </font>       <p align="left"><font face="Verdana" size="2"><a name="figura_10"></a><img style="width: 566px; height: 286px;" alt="" src="/img/revistas/ruc/v28n1/1a09f10.JPG">    <br>        </font>        </p>        <font face="Verdana" size="2">&nbsp;La complacencia ventricular derecha juega un rol importante en la magnitud  de la IP. El ETT tambi&eacute;n hace su aporte en este aspecto. En la <a href="#figura_11">figura 11</a>  reproducimos un hallazgo descrito y evaluado por Gatzoulis y colaboradores</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#45">45</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".45"></a>.     <br>     </font>       <p align="left"><font face="Verdana" size="2"><a name="figura_11"></a><img style="width: 566px; height: 400px;" alt="" src="/img/revistas/ruc/v28n1/1a09f11.JPG">    <br>        </font>        </p>         <font face="Verdana" size="2">Este hallazgo indica la existencia de una fisiolog&iacute;a restrictiva del VD,  que resulta de importancia a la hora de evaluar la repercusi&oacute;n funcional  de la IP.&nbsp; </font>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Aunque la fisiolog&iacute;a restrictiva del VD implica una hemodin&aacute;mica anormal,  la misma limita la magnitud de la regurgitaci&oacute;n. Los autores demuestran  que este hallazgo se correlaciona con mejor tolerancia al ejercicio y mayor  consumo m&aacute;ximo de ox&iacute;geno en el esfuerzo de los pacientes, quienes al mismo  tiempo presentan menos cardiomegalia. En concordancia con esto, Carvalho  y colaboradores</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#46">46</a></font><font face="Verdana" size="2">)<a name=".46"></a></font></sup><font face="Verdana" size="2"> comprueban que los pacientes con mayor grado de IP  residual logran menor duraci&oacute;n total del ejercicio, menor frecuencia card&iacute;aca  m&aacute;xima alcanzada y consumo de ox&iacute;geno m&aacute;ximo m&aacute;s bajo que los controles.&nbsp; </font></p>          <font face="Verdana" size="2">              <br>           </font>               <p align="left"><font face="Verdana" size="2"> <b>Evaluaci&oacute;n de la remodelaci&oacute;n de cavidades derechas&nbsp;</b> </font></p>               <p align="left"><font face="Verdana" size="2"> Cuanto mayor la IP, mayor sobrecarga volum&eacute;trica del VD. El di&aacute;metro telediast&oacute;lico  del VD medido en paraesternal eje largo correlaciona adecuadamente con  estimaciones del volumen ventricular derecho efectuadas mediante RNM (r  = 0,49; p = 0,001)</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#44">44</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. Estos autores demuestran que el grado de IP, as&iacute;  como su repercusi&oacute;n sobre las dimensiones cavitarias del VD, puede realizarse  con ETT y por RNM con razonable concordancia entre ambas t&eacute;cnicas.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> La repercusi&oacute;n de la sobrecarga ventricular derecha sobre la motilidad  del septum interventricular constituye un hallazgo conocido. El movimiento  septal asincr&oacute;nico o &ldquo;parad&oacute;jico&rdquo; es expresi&oacute;n de sobrecarga ventricular  derecha tanto sist&oacute;lica como diast&oacute;lica (</font><font color="#1f1a17" face="Verdana" size="2"><a href="#figura_12">figuras 12 A y B</a></font><font face="Verdana" size="2">).&nbsp; </font></p>                <p><font face="Verdana" size="2">En condiciones de carga normales, en la proyecci&oacute;n parasternal eje corto  a nivel de los m&uacute;sculos papilares, el eje &aacute;ntero-posterior del VI y su  perpendicular son iguales entre s&iacute;, ya que la cavidad presenta una forma  circular tanto en di&aacute;stole como en s&iacute;stole. La relaci&oacute;n entre estas dos  dimensiones se conoce como &iacute;ndice de excentricidad </font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#37">37</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#47">47</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#48">48</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".47"></a><a name=".48"></a>.&nbsp; </font></p>           <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"> Tanto la sobrecarga sist&oacute;lica como la sobrecarga diast&oacute;lica del VD alteran  el &iacute;ndice de excentricidad. En ambas situaciones, el &iacute;ndice se torna mayor  a 1,00, pero con la peculiaridad que en la sobrecarga diast&oacute;lica esta situaci&oacute;n  tiende a corregirse en s&iacute;stole (</font><font color="#1f1a17" face="Verdana" size="2"><a href="#figura_12">figura 12 D</a></font><font face="Verdana" size="2">) mientras que si la sobrecarga  es sist&oacute;lica, esta relaci&oacute;n no se modifica o puede exacerbarse durante  la s&iacute;stole (</font><font color="#1f1a17" face="Verdana" size="2"><a href="#figura_12">figura 12 E y F</a></font><font face="Verdana" size="2">). El hallazgo es significativo porque estas  distorsiones afectan la funci&oacute;n diast&oacute;lica del VI</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#47">47</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"> por la interdependencia  que existe entre ambos ventr&iacute;culos.&nbsp;</font></p>         <p align="left">&nbsp;</p>               <p align="left"><font face="Verdana" size="2"><a name="figura_12"></a><img style="width: 566px; height: 790px;" alt="" src="/img/revistas/ruc/v28n1/1a09f12.JPG">    <br>        </font>        </p>        <font face="Verdana" size="2">&nbsp;<b>Comentarios&nbsp;</b> </font>       ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Es posible afirmar, entonces, que el ETT brinda importante informaci&oacute;n  en la evaluaci&oacute;n del posoperatorio alejado de la cirug&iacute;a correctiva de  tetralog&iacute;a de Fallot. T&eacute;cnicas en desarrollo como la ecocardiograf&iacute;a tridimensional  probablemente se transformen en el instrumento id&oacute;neo para la evaluaci&oacute;n  de esta situaci&oacute;n cl&iacute;nica, pero, hasta el momento, el patr&oacute;n de referencia  sigue siendo la RNM</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#9">9</a></font><font face="Verdana" size="2">-</font><font color="#1f1a17" face="Verdana" size="2"><a href="#13">13</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. En nuestra opini&oacute;n esta t&eacute;cnica debe realizarse  en todo paciente con IP significativa con dilataci&oacute;n ventricular derecha.  El motivo principal lo constituye la estimaci&oacute;n del volumen ventricular  derecho, de considerable importancia pron&oacute;stica en estos pacientes.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> La falla ventricular izquierda favorece la IP porque aumenta la presi&oacute;n  veno-capilar pulmonar y, como consecuencia, disminuye el efecto &ldquo;v&aacute;lvula-s&iacute;mil&rdquo;  del lecho vascular pulmonar. En cambio, la falla ventricular derecha resulta  contenedora</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#14">14</a></font><font face="Verdana" size="2">) </font> </sup><font face="Verdana" size="2">por aumento de la presi&oacute;n diast&oacute;lica final del VD y porque  disminuye su complacencia. Por ello, en la evaluaci&oacute;n de estos pacientes  resulta relevante la valoraci&oacute;n de la funci&oacute;n sist&oacute;lica y diast&oacute;lica de  ambos ventr&iacute;culos, que adem&aacute;s tienen importante interdependencia entre  ambos</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#8">8</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#16">16</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>                <p><font face="Verdana" size="2">En el posoperatorio de la tetralog&iacute;a de Fallot existen b&aacute;sicamente dos  escenarios posibles: 1) el de la obstrucci&oacute;n pulmonar residual con grados  variables de obstrucci&oacute;n, hipertrofia ventricular derecha y fisiolog&iacute;a  restrictiva, o bien 2) el de la IP con diversos grados de regurgitaci&oacute;n  y dilataci&oacute;n ventricular derecha. De acuerdo al conocimiento actual de  este problema, el primero de estos escenarios parece ser el m&aacute;s conveniente.  La estrategia quir&uacute;rgica adoptada puede determinar cu&aacute;l de estos escenarios  tendr&aacute; lugar. En un extremo, con IP &ldquo;libre&rdquo; y nula obstrucci&oacute;n residual,  y, en el otro, con alg&uacute;n grado de obstrucci&oacute;n residual y niveles variables  de incompetencia valvular pulmonar.&nbsp; </font></p>           <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"> Las primeras estrategias quir&uacute;rgicas se inclinaban por la realizaci&oacute;n de  ventriculotom&iacute;as generosas y uso liberal de parche transanular. Esto conduc&iacute;a  a IP &ldquo;libre&rdquo; y TSVD no contr&aacute;ctiles</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#7">7</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. Actualmente una estrategia quir&uacute;rgica  conservadora se considera preferible porque disminuye la magnitud de la  regurgitaci&oacute;n, preserva la funci&oacute;n del VD y disminuye la incidencia de  arritmias</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#49">49</a></font><font face="Verdana" size="2">-</font><font color="#1f1a17" face="Verdana" size="2"><a href="#51">51</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".49"></a><a name=".50"></a><a name=".51"></a>. La oportunidad del reemplazo valvular pulmonar constituye  el punto crucial en la atenci&oacute;n de estos pacientes a largo plazo. El reemplazo  oportuno permite r&aacute;pida disminuci&oacute;n del volumen y masa del VD, si su volumen  diast&oacute;lico antes de la cirug&iacute;a no excede 150 ml/m</font><sup><font face="Verdana" size="2">2(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#52">52</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".52"></a>. Therrien y colaboradores</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#53">53</a></font><font face="Verdana" size="2">)<a name=".53"></a></font></sup><font face="Verdana" size="2">  encuentran posibilidad de reversi&oacute;n de la dilataci&oacute;n del VD si se procede  al reemplazo valvular antes que la cavidad exceda un volumen diast&oacute;lico  de 170 ml/m<sup>2</sup> o un volumen sist&oacute;lico de 85 ml/m</font><font face="Century Schoolbook" size="2"><font face="Verdana"><sup>2</sup></font><font face="Verdana" size="2">. De manera similar, Oosterhof  y colaboradores</font></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#54">54</a></font><font face="Verdana" size="2">)<a name=".54"></a> </font> </sup><font face="Verdana" size="2">encuentran como punto de corte adecuado las dimensiones  de 160 y 82 ml/m<sup>2</sup> para los vol&uacute;menes diast&oacute;lico y sist&oacute;lico del VD, respectivamente.  Estos autores concluyen que aun los pacientes con vol&uacute;menes muy elevados  del VD y disfunci&oacute;n sist&oacute;lica pueden disminuir significativamente la dilataci&oacute;n  despu&eacute;s del reemplazo valvular pulmonar. Sin embargo, otros autores sostienen  que el reemplazo valvular pulmonar debe realizarse antes de que la funci&oacute;n  sist&oacute;lica del VD se deteriore</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#55">55</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".55"></a>.&nbsp; </font></p>          <font face="Verdana" size="2">              <br>           </font>               <p align="left"><font face="Verdana" size="2"> <b>Alteraciones el&eacute;ctricas&nbsp;</b> </font></p>               <p align="left"><font face="Verdana" size="2"> La presencia de flutter, fibrilaci&oacute;n atrial o taquicardia ventricular implica  la existencia de alteraciones hemodin&aacute;micas severas</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#56">56</a></font><font face="Verdana" size="2">-</font><font color="#1f1a17" face="Verdana" size="2"><a href="#58">58</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".56"></a><a name=".57"></a><a name=".58"></a>. Una duraci&oacute;n  de QRS superior a 180 mseg constituye un importante factor de riesgo para  el desarrollo de taquicardia ventricular y muerte s&uacute;bita </font><sup> <font face="Verdana" size="2"> (</font><font color="#1f1a17" face="Verdana" size="2"><a href="#49">49</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#59">59</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".59"></a>. El bloqueo  de rama derecha (BRD) detectado inmediatamente despu&eacute;s de la cirug&iacute;a se  vincula al acto quir&uacute;rgico. El BRD que se produce tard&iacute;amente se vincula  principalmente a la dilataci&oacute;n ventricular derecha y esta a la IP. Por  lo tanto, el ensanchamiento progresivo del QRS en relaci&oacute;n con una situaci&oacute;n  previa tiene mayor valor pron&oacute;stico que la magnitud del ensanchamiento  en s&iacute;</font><sup><font color="#1f1a17" face="Verdana" size="2"><a href="#49">(49</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#57">57</a></font><font face="Verdana" size="2">-</font><font color="#1f1a17" face="Verdana" size="2"><a href="#59">59</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>          <font face="Verdana" size="2">              <br>           </font>               <p align="left"><font face="Verdana" size="2"> <b>Indicaciones de sustituci&oacute;n valvular pulmonar&nbsp;</b> </font></p>               <p align="left"><font face="Verdana" size="2"> Las gu&iacute;as del American College of Cardiology </font><sup><font face="Verdana" size="2"> (</font><font color="#1f1a17" face="Verdana" size="2"><a href="#58">58</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"> recomiendan el reemplazo  valvular pulmonar cuando existe IP severa y s&iacute;ntomas o disminuci&oacute;n del  nivel de tolerancia al ejercicio (clase I/nivel de evidencia B) y consideran  razonable el reemplazo valvular pulmonar (indicaci&oacute;n clase IIa) en adultos  con tetralog&iacute;a de Fallot e IP severa con cualquiera de los siguientes hallazgos:  a) moderada a severa disfunci&oacute;n ventricular derecha (nivel de evidencia  B); b) moderada a severa dilataci&oacute;n del VD (nivel de evidencia B); c) desarrollo  de arritmias atriales y/o ventriculares sintom&aacute;ticas o sostenidas (nivel  de evidencias C); d) moderada a severa incompetencia valvular tricusp&iacute;dea  (nivel de evidencia C).&nbsp; </font></p>               ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"> Las gu&iacute;as europeas</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#59">59</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"> se&ntilde;alan que en este contexto el reemplazo valvular  pulmonar debe llevarse a cabo en el paciente sintom&aacute;tico con IP severa  y/o estenosis pulmonar con presi&oacute;n sist&oacute;lica del VD mayor de 60 mmHg (velocidad  de regurgitaci&oacute;n tricusp&iacute;dea mayor de 3,5 m/s) (clase I/nivel de evidencia  C) y sostienen que el reemplazo valvular pulmonar debe considerarse en  los pacientes asintom&aacute;ticos con IP severa y/o estenosis pulmonar, cuando  por lo menos uno de los siguientes criterios est&aacute; presente: a) disminuci&oacute;n  de la capacidad objetiva para el ejercicio; b) dilataci&oacute;n ventricular derecha  progresiva; c) disfunci&oacute;n sist&oacute;lica ventricular derecha progresiva; d)  regurgitaci&oacute;n tricusp&iacute;dea progresiva de magnitud por lo menos moderada;  e) obstrucci&oacute;n en el TSVD cuando la presi&oacute;n sist&oacute;lica ventricular derecha  supera 80 mmHg (velocidad de regurgitaci&oacute;n tricusp&iacute;dea superior a 4,3 m/s);  f) arritmias atriales o ventriculares sostenidas (clase IIa/nivel de evidencia  C).&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> En definitiva, en todo paciente con IP severa, cualquiera de las siguientes  condiciones constituyen indicaci&oacute;n para reemplazar la v&aacute;lvula pulmonar</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#49">49</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">:  1) s&iacute;ntomas cl&iacute;nicos o disminuci&oacute;n de la tolerancia para el ejercicio;  2) evidencias de disfunci&oacute;n ventricular derecha; 3) evidencias de dilataci&oacute;n  ventricular derecha (170 ml/m<sup>2</sup> en di&aacute;stole o 85 ml/m</font><font face="Century Schoolbook" size="2"><font face="Verdana"><sup>2</sup></font><font face="Verdana" size="2"> en s&iacute;stole), seg&uacute;n  este autor; 4) arritmias auriculares o ventriculares; 5) insuficiencia  tricusp&iacute;dea progresiva; 6) QRS prolongado (180 mseg)</font></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#49">49</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#54">54</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. La RNM y los  estudios electrofisiol&oacute;gicos ayudan a determinar la oportunidad del reemplazo.  Varios estudios abogan a favor del reemplazo valvular temprano y coinciden  en que mejora el pron&oacute;stico en la medida que normaliza los vol&uacute;menes del  VD, la funci&oacute;n biventricular y mejora la tolerancia al ejercicio</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#50">50</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. Un  metaan&aacute;lisis publicado en el 2010</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#60">60</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".60"></a> incluy&oacute; la revisi&oacute;n de 15 estudios  seleccionados entre 305 publicaciones que evaluaban la evoluci&oacute;n temprana  y alejada del reemplazo quir&uacute;rgico de la v&aacute;lvula pulmonar en el posoperatorio  de cirug&iacute;a reparadora de tetralog&iacute;a de Fallot. Se excluyeron trabajos de  revisi&oacute;n, informes de casos aislados y tambi&eacute;n sustituci&oacute;n percut&aacute;nea de  la v&aacute;lvula pulmonar por carecer estos &uacute;ltimos de datos sobre evoluci&oacute;n  alejada. En conjunto este metaan&aacute;lisis incluy&oacute; la evaluaci&oacute;n pron&oacute;stica  de un total de 736 pacientes a quienes se les sustituy&oacute; la v&aacute;lvula pulmonar.  Se concluye que este procedimiento es de baja mortalidad temprana y tard&iacute;a  y se documenta disminuci&oacute;n significativa de los vol&uacute;menes del VD. Sin embargo,  no se producen cambios significativos en la fracci&oacute;n de eyecci&oacute;n del VD  ni en la duraci&oacute;n del QRS. Tampoco est&aacute; claro si el reemplazo valvular  pulmonar reduce el riesgo de arritmias card&iacute;acas o de muerte s&uacute;bita</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#50">50</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">.&nbsp; </font></p>            <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"><b>Conclusiones&nbsp;</b> </font></p>               <p align="left"><font face="Verdana" size="2"> No contamos con datos oficiales de la incidencia de regurgitaci&oacute;n valvular  pulmonar (IP) en el posoperatorio alejado de cirug&iacute;a correctiva de tetralog&iacute;a  de Fallot en pacientes operados en nuestro medio. En ese sentido, la revisi&oacute;n  de datos procedentes del Fondo Nacional de Recursos (FNR) podr&iacute;a proporcionarnos  informaci&oacute;n de gran importancia para conocer cu&aacute;l es la situaci&oacute;n. En t&eacute;rminos  generales se considera que la IP significativa es frecuente en el posoperatorio  alejado de cirug&iacute;a correctiva de tetralog&iacute;a de Fallot</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#61">61</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#62">62</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".61"></a><a name=".62"></a>. Resulta claro  que la incidencia de la misma depende en parte de la t&eacute;cnica quir&uacute;rgica  utilizada y de la &eacute;poca en que se realiz&oacute; la cirug&iacute;a, pero de todos modos  la IP constituye uno de los principales problemas del posoperatorio de  cirug&iacute;a correctiva de tetralog&iacute;a de Fallot</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#63">63</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".63"></a>. La incidencia documentada  en la literatura resulta bastante variable, seg&uacute;n diversos centros y autores,  por las razones que coment&aacute;bamos previamente, pero oscila entre 19% y 64%</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#64">64</a></font><font face="Verdana" size="2">-</font><font color="#1f1a17" face="Verdana" size="2"><a href="#66">66</a></font><font face="Verdana" size="2">)<a name=".64"></a><a name=".65"></a><a name=".66"></a> </font>  </sup><font face="Verdana" size="2">y hasta 100% en algunas instituciones cuando la t&eacute;cnica empleada es parche  transanular</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#67">67</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".67"></a>. Resulta dificultoso establecer la incidencia precisa porque  algunos trabajos eval&uacute;an la magnitud de la incompetencia pulmonar en funci&oacute;n  de la dilataci&oacute;n del VD efectuando especulaciones respecto a la responsabilidad  que le cabe a la misma en esta dilataci&oacute;n</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#68">68</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".68"></a>, pero reconocidos cirujanos,  como Roger Mee, comentan al respecto de estos trabajos que adem&aacute;s de la  variables mencionadas existen otras causas de sobrecarga volum&eacute;trica del  VD en la cirug&iacute;a correctiva de tetralog&iacute;a de Fallot, por ejemplo el efecto  de sobrecarga que se produce como consecuencia del cierre quir&uacute;rgico del  defecto septal ventricular</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#69">69)</a></font></sup><font face="Verdana" size="2"><a name=".69"></a>. Comentarios adicionales al respecto pueden  encontrarse en Murphy y Fuster</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#70">70</a></font><font face="Verdana" size="2">,</font><font color="#1f1a17" face="Verdana" size="2"><a href="#71">71</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"><a name=".70"></a><a name=".71"></a>. Sea como fuere, se admite que la  incompetencia valvular pulmonar constituye un problema significativo en  el posoperatorio alejado de la cirug&iacute;a correctiva de tetralog&iacute;a de Fallot</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#63">63)</a></font></sup><font face="Verdana" size="2">.  La IP cr&oacute;nica tiene un efecto perjudicial sobre la funci&oacute;n del VD, la tolerancia  al ejercicio y conduce a un riesgo aumentado de arritmias y muerte s&uacute;bita</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#1">1)</a></font></sup><font face="Verdana" size="2">.  La severidad de la IP y su impacto sobre la funci&oacute;n del VD puede ser evaluada  cuantitativamente por RNM (por el momento patr&oacute;n de referencia), pero tambi&eacute;n  mediante ETT</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#1">1</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2"> de uso corriente en la evaluaci&oacute;n cl&iacute;nica habitual de nuestros  pacientes con importante correlaci&oacute;n entre esta t&eacute;cnica y los datos aportados  por la RNM</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#44">44)</a></font></sup><font face="Verdana" size="2">.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> Sin duda, la ecocardiograf&iacute;a tridimensional y t&eacute;cnicas de reciente desarrollo  como <i>strain, strain rate </i>y<i> speckle tracking imaging</i></font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#72">72</a></font><font face="Verdana" size="2">)<a name=".72"></a></font></sup><font face="Verdana" size="2"> probablemente adquieran  un rol preponderante en la evaluaci&oacute;n de estos pacientes, en la medida  en que su disponibilidad sea m&aacute;s extendida y que estudios adecuadamente  dise&ntilde;ados optimicen su utilidad.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"> Debe tenerse presente que un n&uacute;mero cada vez mayor de adultos con valvulotom&iacute;a  previa, o reparaci&oacute;n de tetralog&iacute;a de Fallot, requerir&aacute;n reemplazo valvular  pulmonar electivo antes de que sobrevenga una disfunci&oacute;n ventricular derecha  irreversible</font><sup><font face="Verdana" size="2">(</font><font color="#1f1a17" face="Verdana" size="2"><a href="#1">1</a></font><font face="Verdana" size="2">)</font></sup><font face="Verdana" size="2">. Esta revisi&oacute;n nos permite concluir que independientemente  de los avances que las t&eacute;cnicas de imagen han tenido en los &uacute;ltimos tiempos,  la ETT convencional sigue siendo una herramienta &uacute;til para la evaluaci&oacute;n  rutinaria de estos pacientes. M&uacute;ltiples estudios demuestran que los datos  obtenidos por esta t&eacute;cnica se correlacionan satisfactoriamente con los  procedimientos de referencia.&nbsp; </font></p>            <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"><b>Bibliograf&iacute;a&nbsp;</b> </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="1"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.1">1</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Bouzas B, Kilner PJ, Gatzoulis MA. </b>Pulmonary regurgitation: not a benign  lesion. Eur Heart J 2005; 26:433-9.    &nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="2"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.2">2</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Wessel HU, Cunningham WJ, Paul MH, Bastanier CK, Muster AJ, Idriss FS.</b>  Exercise performance in tetralogy of Fallot after intracardiac repair.  J Thorac Cardiovasc Surg 1980; 80: 582&ndash;93.&nbsp; </font></p>               ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"><a name="3"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.3">3</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Carvalho JS, Shinebourne EA, Busst C, Rigby ML, Redington AN.</b> Exercise  capacity after complete repair of tetralogy of Fallot: deleterious effects  of residual pulmonary regurgitation. Br Heart J 1992; 67: 470&ndash;3.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="4"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#.4"> 4</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;R<b>edington AN, Oldershaw PJ, Shinebourne EA, Rigby ML. </b>A new technique  for the assessment of pulmonary regurgitation and its application to the  assessment of right ventricular function before and after repair of tetralogy  of Fallot. Br Heart J 1988; 60:57&ndash;65.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="5"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.5">5</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Marie PY, Marcon F, Brunotte F, Briancon S, Danchin N, Worms AM, et al.</b>  Right ventricular overload and induced sustained ventricular tachycardia  in operatively &ldquo;repaired&rdquo; tetralogy of Fallot. Am J Cardiol 1992; 69:785&ndash;9. &nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="6"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#.6"> 6</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Gatzoulis MA, Balaji S, Webber SA, Siu SC, Hokanson JS, Poile C, et al.</b>  Risk factors for arrhythmia and sudden cardiac death late after repair  of tetralogy of Fallot: a multicentre study. Lancet 2000; 356:975&ndash;81.&nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="7"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.7">7</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Shimizaki Y, Blacstone EH, Kirklin JW.</b> The natural history of isolated  congenital pulmonary valve incompetence: surgical implications. Thorac  Cardiovascular Surg 1984; 32: 257-9.    &nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="8"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.8">8</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Geva T, Sandweiss BM, Gauvreau K, Lock JE, Powell AJ. </b>Factors associated  with impaired clinical status in long-term survivors of tetralogy of Fallot  repair evaluated by magnetic resonance imaging. J Am Coll Cardiol 2004;  43:1068&ndash;74.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="9"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.9">9</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Davlouros PA, Kilner PJ, Hornung TS, Li W, Francis JM, Moon JCC, et al.</b>  Right ventricular function in adults with repaired tetralogy of Fallot  assessed with cardiovascular magnetic resonance imaging: detrimental role  of right ventricular outflow aneurysms or akinesia and adverse right-to-left  ventricular interaction. J Am Coll Cardiol 2002; 40: 2044&ndash;52.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="10"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.10">10</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Wald RM, Redington AN, Pereira A, Provost YL, Paul NS, Oechslin EN,  et al.</b> Refining the assessment of pulmonary regurgitation in adults after  tetralogy of Fallot repair: should we be measuring regurgitant fraction  or regurgitant volume? Eur Heart J 2009; 30: 356&ndash;61.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="11"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.11">11</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ. </b>Interstudy  reproducibility of right ventricular volumes, function, and mass with cardiovascular  magnetic resonance. Am Heart J 2004; 147:218&ndash;23.&nbsp; </font></p>               ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"><a name="12"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.12">12</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Rebergen SA, Chin JG, Ottenkamp J, van der Wall EE, de Roos A.</b> Pulmonary  regurgitation in the late postoperative follow-up of tetralogy of Fallot.  Volumetric quantitation by nuclear magnetic resonance velocity mapping.  Circulation 1993; 88: 2257&ndash;66.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="13"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.13">13</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Oosterhof T, Mulder BJ, Vliegen HW, de Roos A. </b>Cardiovascular magnetic  resonance in the follow-up of patients with corrected tetralogy of Fallot:  a review. Am Heart J 2006; 151:265&ndash;72.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="14"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.14">14</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Therrien J, Gatzoulis M, Graham T, Bink-Boelkens M, Connelly M, Niwa  K, et al.</b> Canadian Cardiovascular Society Consensus Conference 2001 update:  Recommendations for the management of adults with congenital heart disease&mdash;Part  II. Can J Cardiol 2001; 17: 1029&ndash;50.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="15"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.15">15</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Kilner PJ.</b> Pulmonary regurgitation in relation to pulmonary artery compliance  and other variables. In: Redington AN, Van Arsdell GS, Anderson RH eds.  Congenital heart diseases in the right heart. London: Springer&ndash;Verlag,  2009:247-50.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="16"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.16">16</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Ilbawi MN, Idriss FS, DeLeon SY, Muster AJ, Gidding SS, Berry TE, et  al.</b> Factors that exaggerate the deleterious effects of pulmonary insufficiency  on the right ventricle after tetralogy repair. Surgical implications. J  Thorac Cardiovasc Surg 1987;93:36&ndash;44.&nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="17"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.17">17</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Kilner PJ. </b>Pulmonary resistance in cardiovascular context. Int J Cardiol.  2004; 97:3-6&nbsp;     </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="18"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.18">18</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Abbas AE, Fortuin FD, Schiller NB, Appleton CP, Moreno CA, Lester SJ.</b>  A simple method for noninvasive estimation of pulmonary vascular resistance.  J Am Coll Cardiol 2003; 41:1021-7.    &nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="19"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.19">19</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Okamoto M, Miyatake K, Kinoshita N, Sakakibara H, Nimura Y. </b>Analysis  of blood flow in pulmonary hypertension with the pulsed Doppler flowmeter  combined with cross-sectional echocardiography. Br Heart J 1984; 51:407&ndash;15. &nbsp; </font></p>               ]]></body>
<body><![CDATA[<p align="left"><font face="Verdana" size="2"><a name="20"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.20">20</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Hirschfeld S, Meyer R, Schwartz DC, Kofhagen J, Kaplan S.</b> The echocardiographic  assessment of pulmonary artery pressure and pulmonary vascular resistance.  Circulation 1975; 52: 642&ndash;50.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="21"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.21">21</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Matsuda M, Sekiguchi T, Sugishita Y, Kuwako K, K Iida, Ito I. </b>Reliability  of non-invasive estimates of pulmonary hypertension by pulsed Doppler echocardiography.  Br Heart J 1986; 56: 158&ndash;64.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="22"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.22">22</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Chan KL, Currie PJ, Seward JB, Hagler DJ, Mair DD, Tajik AJ. </b>Comparison  of three Doppler ultrasound methods in the prediction of pulmonary artery  pressure. J Am Coll. Cardiol 1987; 9: 549&ndash;54.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="23"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.23">23</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Murata I, Sonoda M, Morita T, Nakamura F, Takenaka K, Nagai R. </b>The clinical  significance of reversed flow in the main pulmonary artery detected by  Doppler color flow imaging. Chest 2000; 118: 336&ndash;41.&nbsp; </font></p>                <p><font face="Verdana" size="2"><a name="24"></a> </font> <font color="#1f1a17" face="Verdana" size="2"><a href="#.24">24</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Riggs T, Hirschfeld S, Borkat G, Knoke J, Liebman J. </b>Assessment of the  pulmonary vascular bed by echocardiographic right ventricular systolic  time intervals. Circulation 1978; 57: 939&ndash;47.&nbsp; </font> <multicol gutter="18" cols="2"></multicol> </p>              <p align="left"><font face="Verdana" size="2"><a name="25"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.25">25</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Scapellato F, Temporelli PL, Eleuteri E, Corr&agrave; U, Imparato A, Giannuzzi  P. </b>Accurate noninvasive estimation of pulmonary vascular resistance by  Doppler echocardiography in patients with chronic failure heart failure.  J Am Coll Cardiol 2001; 37: 1813&ndash;9.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="26"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.26">26</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Shandas R, Weinberg C, Ivy DD, Nicol E, DeGroff CG, Hertzberg J, et  al.</b> Development of a noninvasive ultrasound color M-mode means of estimating  pulmonary vascular resistance in pediatric pulmonary hypertension: mathematical  analysis, in vitro validation, and preliminary clinical studies. Circulation  2001; 104:908&ndash;13.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="27"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.27">27</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Tahara M, Tanaka H, Nakao S, Yoshimura H, Sakurai S, Tei C, et al.</b> Hemodynamic  determinants of pulmonary valve motion during systole in experimental pulmonary  hypertension. Circulation 1981; 64 : 1249&ndash;55.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="28"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.28">28</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Ebeid MR, Ferrer PL, Robinson B, Weatherby N, Gelband H. </b>Doppler echocardiographic  evaluation of pulmonary vascular resistance in children with congenital  heart disease. J Am Soc Echocardiogr 1996; 9: 822&ndash;31.&nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="29"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.29">29</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Davlouros PA, Niwa K, Webb G, Gatzoulis MA. </b>The right ventricle in congenital  heart disease. Heart 2006; 92: i27-i38&nbsp;     </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="30"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.30">30</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Anavekar NS, Gerson D, Skali H, Kwong RY, Yucel EK, Solomon SD.</b> Two-dimensional  assessment of right ventricular function: an Echocardiographic-MRI correlative  study. Echocardiography 2007; 24: 452-6.    &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="31"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.31">31</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Mor-Avi V, Lang RM, Badano LP, Belohlavek M, Cardim NM, Derumeaux G,  et al.</b> Current and evolving echocardiographic techniques for the quantitative  evaluation of cardiac mechanics: ASE/EAE Consensus Statement on Methodology  and Indications: Endorsed by the Japanese Society of Echocardiography.  J Am Soc Echocardiogr 2011; 24:277-313.    &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="32"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.32">32</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Ueti OM, Camargo EE, Ueti Ade A, de Lima-Filho EC, Nogueira EA, et al.</b>  Assessment of right ventricular function with Doppler echocardiographic  indices derived from tricuspid annular motion: comparison with radionuclide  angiography. Heart 2002; 88: 244-8.    &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="33"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.33">33</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug  BA, et al. </b>Tricuspid annular displacement predicts survival in pulmonary  hypertension. Am J Respir Crit Care Med 2006; 174: 1034-41.    &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="34"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.34">34</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Tei C. </b>New non-invasive index for combined systolic and diastolic ventricular  function. J Cardiol 1995; 26:135-36.    &nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="35"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.35">35</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Tei C, Dujardin KS, Hodge DO, Bailey KR, McGoon MD, Tajik AJ, et al.</b>  Doppler echocardiographic index for assessment of global right ventricular  function. J Am Soc Echocardiogr 1996; 9: 838 &ndash; 46.&nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="36"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.36">36</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Tei C, Nishimura RA, Seward JB, Tajik AJ.</b> Noninvasive Doppler-derived  myocardial perfomance index: Correlation with simultaneous measurements  of cardiac catheterization measurements. J Am Soc Echocardiogr 1997; 10:  169-78.    &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="37"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.37">37</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Jurcut R, Giusca S, La Gerche A, Vasile S, Ginghina C, Voigt J-U. </b>The  echocardiographic assessment of the right ventricle: what to do in 2010?  Eur J Echocardiogr 2010;11:81-96.    &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="38"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.38">38</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran  K, et al.</b> Guidelines for the echocardiographic assesment of the right heart  in adults: A report from the American Society of Echiocardiography. Endosed  by the European Association of Echocardiography, a registered branch of  the European Society of Cardiology, and the Canadian Society of Echocardiography.  J Am Soc Echocardiogr 2010; 23: 685-713.    &nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="39"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.39">39</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Gin&eacute;s F, Grignola JC.</b> Sincronizaci&oacute;n de la contracci&oacute;n del ventr&iacute;culo  derecho frente a un aumento agudo de su postcarga. &ldquo;Izquierdizaci&oacute;n&rdquo; del  comportamiento mec&aacute;nico del ventr&iacute;culo derecho. Rev Esp Cardiol 2001; 54:  973-80.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="40"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.40">40</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Grignola JC, Gin&eacute;s F. Guzzo D. </b>Comparison of the Tei index with invasive  measurments of right ventricular function. Int J Cardiol 2006; 113: 25  &ndash; 33.&nbsp; </font></p>               ]]></body>
<body><![CDATA[<!-- ref --><p align="left"><font face="Verdana" size="2"><a name="41"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.41">41</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Vogel M, Schmidt MR, Kristiansen SB, Cheung M, White PA, Sorensen K,  et al.</b> Validation of myocardial acceleration during Isovolumic contraction  as a novel noninvasive index of right ventricular contractility comparison  with ventricular pressure-volume relations in an animal model. Circulation  2002; 105:1693-9.    &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="42"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.42">42</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Haddad F, Hunt SA, Rosenthal DN, Murphy DJ.</b> Right ventricular function  in cardiovascular disease, Part I: Anatomy, physiology, aging, and functional  assessment of the right ventricle. Circulation 2008; 117:1436-48.    &nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="43"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.43">43</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>D&rsquo;Cruz IA. </b>Conventional and Color Doppler Assessment of Right-Sided  Lesions. In: Nanda NC. Doppler Echocardiograophy. 2nd. ed. Philadelphia:  London, 1993: 145-59.&nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="44"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.44">44</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Li W, Davlouros PA, Kilner PJ, Pennell DJ, Gibson D, Henein MY, et al.</b>  Doppler-echocardiographic assessment of pulmonary regurgitation in adults  with repaired tetralogy of Fallot: Comparison with cardiovascular magnetic  resonance imaging. Am Heart J 2004; 147: 165-72.    &nbsp; </font></p>                <!-- ref --><p><font face="Verdana" size="2"><a name="45"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#.45">45</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Gatzoulis MA, Clark AL, Cullen S, Newman CGH, Redington AN. </b>Right Ventricular  Diastolic Function 15 to 35 Years After Repair of Tetralogy of Fallot.  Restrictive Physiology Predicts Superior Exercise Performance. Circulation  1995; 91:1775-81.    &nbsp; </font></p>           <multicol gutter="18" cols="2"></multicol>     <p align="left"><font face="Verdana" size="2"><a name="46"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.46">46</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Carvalho JS, Shinebourne EA, Busst C, Rigby ML, Redington AN.</b> Exercise  capacity after complete repair of tetralogy of Fallot: deleterious effects  of residual pulmonary regurgitation. Br Heart J 1992; 67: 470&ndash;3.&nbsp; </font></p>               ]]></body>
<body><![CDATA[<!-- ref --><p align="left"><font face="Verdana" size="2"><a name="47"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.47">47.</a></font><font face="Verdana" size="2">&nbsp;&nbsp;&nbsp;&nbsp;<b>Louie EK, Rich S, Levitsky S, Brundage BH. </b>Doppler echocardiographic  demonstration of the differential effects of right ventricular pressure  and volume overload on left ventricular geometry and filling. J Am Coll  Cardiol 1992; 19: 84-90.    &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="48"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.48">48</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>King ME, Braun H, Goldblatt A, Liberthson R, Weyman AE.</b> Interventricular  septal configuration as a predictor of right ventricular systolic hypertension  in children: a cross-sectional echocardiographic study. Circulation 1983;  68: 68-75.    &nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="49"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.49">49</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Guleserian KJ. </b>Adult Congenital Heart Disease: Surgical advances and  options. Prog Cardiovasc Dis 2011; 53: 254&ndash;264&nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="50"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.50">50</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Stewart RD, Backer CL, Young L, Mavroudis C.</b> Tetralogy of Fallot: Results  of a pulmonary valve-sparing strategy. Ann Thorac Surg 2005; 80: 1431-1439.     &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="51"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.51">51</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Boni L, Garcia E, Galletti L, P&eacute;rez A, Herrera D, Ramos V, et al.</b> Current  strategies in tetralogy of Fallot repair: pulmonary valve sparing and evolution  of right ventricle/left ventricle pressures ratio. Eur J Cardiothorac Surg  2009; 35:885-9.    &nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="52"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.52">52</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Valsangiacomo ER, Hitendu HD, Kellenberger CJ, Dodge-Khatami A, Petre  R, Berger F, et al.</b> Remodelling of the right ventricle after early pulmonary  valve replacement in children with repaired tetralogy of Fallot: assessment  by cardiovascular magnetic resonance. Eur Heart J 2005; 26: 2721&ndash;7.&nbsp; </font></p>               ]]></body>
<body><![CDATA[<!-- ref --><p align="left"><font face="Verdana" size="2"><a name="53"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.53">53</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Therrien J, Provost Y, Merchant N, Williams W, Colman J, Webb G. </b>Optimal  timing for pulmonary valve replacement in adults after tetralogy of Fallot  repair. Am J Cardiol 2005; 95: 779-82.    &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="54"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.54">54</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Oosterhof T, van Straten A, Vliegen HW, Meijboom FJ, van Dijk APJ, Spijkerboer  AM, et al.</b> Preoperative thresholds for pulmonary valve replacement in patients  with corrected Tetralogy of Fallot using cardiovascular magnetic resonance.  Circulation 2007;116:545-51.    &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="55"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.55">55</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Therrien J, Siu SC, McLaughlin PR, Liu PP, Williams WG, Webb GD. </b>Pulmonary  valve replacement in adults late after repair of tetralogy of Fallot: are  we operating too late? J Am Coll Cardiol 2000; 36: 1670-5.    &nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="56"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.56">56</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Harrison DA, Harris L, Siu SC, MacLoghlin CJ, Connelly MS, Webb GD,  et al. </b>Sustained ventricular tachycardia in adult patients late after repair  of tetralogy of Fallot. J Am Coll Cardiol 1997; 30: 1368 &ndash;73.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="57"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.57">57</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Harrison DA, Siu SC, Hussain F, MacLoghlin CJ, Webb GD, Harris L. </b>Sustained  atrial arrhythmias in adults late after repair of tetralogy of Fallot.  Am J Cardiol 2001; 87:584&ndash;5.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="58"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.58">58</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Warnes CA, Williams RG, Bashore TM, Child JS, Connolly HM, Dearani JA,  et al.</b> ACC/AHA 2008 Guidelines for the Management of Adults With Congenital  Heart Disease: A Report of the American College of Cardiology/American  Heart Association Task Force on Practice Guidelines (Writing Committee  to Develop Guidelines on the Management of Adults With Congenital Heart  Disease) Developed in Collaboration With the American Society of Echocardiography,  Heart Rhythm Society, International Society for Adult Congenital Heart  Disease, Society for Cardiovascular Angiography and Interventions, and  Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 52: e143 &ndash; e263. &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="59"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.59">59</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Baumgartner H, Bonhoeffer P, De Groot NMS, de Haan F, Deanfield JE,  Galie N, et al.</b> ESC Guidelines for the management of grown-up congenital  heart disease (new version 2010) The Task Force on the Management of Grown-up  Congenital Heart Disease of the European Society of Cardiology (ESC) Endorsed  by the Association for European Paediatric Cardiology (AEPC). Eur Heart  J 2010; 31: 2915-57.    &nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="60"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#.60"> 60</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Cheung EW, Wong WH, Cheung YF. </b>Meta-analysis of pulmonary valve replacement  after operative repair of Tetralogy of Fallot. Am J Cardiol 2010;106 :552&ndash;7.&nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="61"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.61">61</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Martucci G, Therrien J. </b>Timing and outcome of surgical pulmonary valve  replacement. En: Redington AN, Van Arsdell GS, Anderson RH. Congenital  diseases in right heart. London. Springer-Verlag , 2009:259.    &nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="62"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.62">62</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Siwik ES, Erenberg F, Zahka KG, Goldmuntz E. </b>Tetralogy of Fallot. En:  Allen HD, Driscoll DJ, Shaddy RE, Feltes TF. Moss and Adams&rsquo; heart disease  in infants, children, and adolescents: Including the fetus and young adults.  7th ed. Philadelphia (USA): Lippincott Williams &nbsp;and&nbsp; Wilkins, 2008.&nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="63"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.63">63</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Hoffman JIE.</b> The natural and unnatural history of congenital heart disease.  Chennai (India): John Wiley and&nbsp; Sons Ltd, 2009:412.    &nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="64"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.64">64</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Faidutti B, Christenson JT, Beghetti M, Friedli B, Kalangos A. </b>How to  diminish reoperation rates after initial repair of tetralogy of Fallot?  Ann Thorac Surg. 2002; 73:96&ndash;101.&nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="65"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.65">65</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Herman SG, Baselga P, Parnas Fernandez A, Alvarez C, Soto S, Gonz&aacute;lez A.</b> Evoluci&oacute;n de los pacientes con tetralog&iacute;a de Fallot. Hospital del Ni&ntilde;o  Jes&uacute;s de San Miguel de Tucum&aacute;n. An&aacute;lisis de la base de datos. Rev Fed Arg  Cardiol 2007; 36: 87-93.    &nbsp; </font></p>                ]]></body>
<body><![CDATA[<p><font face="Verdana" size="2"><a name="66"></a> </font> <font color="#1f1a17" face="Verdana" size="2"><a href="#.66">66</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>d&rsquo;Udekem Y, Ovaert C, Grandjean F, Gerin V, Cailteux M, Shango-Lody P, et al. </b>Tetralogy of Fallot: transannular and right ventricularpatching  equally affect late functional status. Circulation. 2000; 102(19 suppl  3): III116&ndash;22.&nbsp; </font> <multicol gutter="18" cols="2"></multicol> </p>              <p align="left"><font face="Verdana" size="2"><a name="67"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#.67"> 67</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Alexiou C, Chen Q, Galogavrou M, Gnanapragasam J, Salmon AP, Keeton  BR, et al.</b> Repair of tetralogy of Fallot in infancy with a transventricular  or a transatrial approach. Eur J Cardiothorac Surg 2002; 22:174&ndash;83.&nbsp; </font></p>               <p align="left"><font face="Verdana" size="2"><a name="68"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.68">68</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Fuster V, McGoon DC, Kennedy MA, Ritter DG, Kirklin JW.</b> Long-term evaluation  (12 to 22 years) of open heart surgery for tetralogy of Fallot. Am J Cardiol  1980; 46(4):635&ndash;42.&nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="69"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.69">69</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Bacha EA, Scheule AM, Zurakowski D, Erickson LC, Hung J, Lang P, et  al.</b> Long-term results after early primary repair of tetralogy of Fallot.  J Thorac Cardiovasc Surg 2001; 122:154-161.    &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="70"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.70">70</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Murphy JG, Gersh BJ, Mair DD, Fuster V, McGoon MD, Ilstrup DM, et al</b>.  Long-term outcome in patients undergoing surgical repair of tetralogy of  Fallot. N Engl J Med 1993; 329:593-9.    &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="71"></a> </font><font color="#1f1a17" face="Verdana" size="2"><a href="#.71"> 71</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Fuster V, McGoon DC, Kennedy MA, Ritter DG, Kirklin JW.</b> Long-term evaluation  (12 to 22 years) of open heart surgery for tetralogy of Fallot. Am.J. Cardiol.  1980; 46: 635 642.    &nbsp; </font></p>               <!-- ref --><p align="left"><font face="Verdana" size="2"><a name="72"></a> </font><font color="#1f1a17" face="Verdana" size="2"> <a href="#.72">72</a></font><font face="Verdana" size="2">.&nbsp;&nbsp;&nbsp;&nbsp;<b>Yuman L, Ge S, Wang X, Lu Q, Xie M.</b> Right ventricular global longitudinal  systolic and diastolic function is diminished in patientswWith pulmonary  arterial hypertension: A 2D ultrasound speckle tracking imaging (Abstract).  Circulation 2009; 120:s387.    &nbsp; </font></p>                   ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bouzas]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Kilner]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gatzoulis]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Pulmonary regurgitation: not a benign lesion]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2005</year>
<volume>26</volume>
<page-range>433-9</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wessel]]></surname>
<given-names><![CDATA[HU]]></given-names>
</name>
<name>
<surname><![CDATA[Cunningham]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Paul]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
<name>
<surname><![CDATA[Bastanier]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
<name>
<surname><![CDATA[Muster]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Idriss]]></surname>
<given-names><![CDATA[FS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Exercise performance in tetralogy of Fallot after intracardiac repair]]></article-title>
<source><![CDATA[J Thorac Cardiovasc Surg]]></source>
<year>1980</year>
<volume>80</volume>
<page-range>582-93</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Shinebourne]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Busst]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rigby]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Redington]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Exercise capacity after complete repair of tetralogy of Fallot: deleterious effects of residual pulmonary regurgitation]]></article-title>
<source><![CDATA[Br Heart J]]></source>
<year>1992</year>
<volume>67</volume>
<page-range>470-3</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Redington]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Oldershaw]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Shinebourne]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Rigby]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A new technique for the assessment of pulmonary regurgitation and its application to the assessment of right ventricular function before and after repair of tetralogy of Fallot]]></article-title>
<source><![CDATA[Br Heart J]]></source>
<year>1988</year>
<volume>60</volume>
<page-range>57-65</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marie]]></surname>
<given-names><![CDATA[PY]]></given-names>
</name>
<name>
<surname><![CDATA[Marcon]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Brunotte]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Briancon]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Danchin]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Worms]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Right ventricular overload and induced sustained ventricular tachycardia in operatively &ldquo;repaired&rdquo; tetralogy of Fallot]]></article-title>
<source><![CDATA[Am J Cardiol]]></source>
<year>1992</year>
<volume>69</volume>
<page-range>785-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gatzoulis]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Balaji]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Webber]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Siu]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Hokanson]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Poile]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Risk factors for arrhythmia and sudden cardiac death late after repair of tetralogy of Fallot: a multicentre study]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2000</year>
<volume>356</volume>
<page-range>975-81</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shimizaki]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Blacstone]]></surname>
<given-names><![CDATA[EH]]></given-names>
</name>
<name>
<surname><![CDATA[Kirklin]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The natural history of isolated congenital pulmonary valve incompetence: surgical implications]]></article-title>
<source><![CDATA[Thorac Cardiovascular Surg]]></source>
<year>1984</year>
<volume>32</volume>
<page-range>257-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Geva]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Sandweiss]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Gauvreau]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Lock]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Powell]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Factors associated with impaired clinical status in long-term survivors of tetralogy of Fallot repair evaluated by magnetic resonance imaging]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2004</year>
<volume>43</volume>
<page-range>1068-74</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davlouros]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Kilner]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hornung]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Francis]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Moon]]></surname>
<given-names><![CDATA[JCC]]></given-names>
</name>
</person-group>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2002</year>
<volume>40</volume>
<page-range>2044-52</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wald]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Redington]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Provost]]></surname>
<given-names><![CDATA[YL]]></given-names>
</name>
<name>
<surname><![CDATA[Paul]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
<name>
<surname><![CDATA[Oechslin]]></surname>
<given-names><![CDATA[EN]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Refining the assessment of pulmonary regurgitation in adults after tetralogy of Fallot repair: should we be measuring regurgitant fraction or regurgitant volume?]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2009</year>
<volume>30</volume>
<page-range>356-61</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grothues]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Moon]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Bellenger]]></surname>
<given-names><![CDATA[NG]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Klein]]></surname>
<given-names><![CDATA[HU]]></given-names>
</name>
<name>
<surname><![CDATA[Pennell]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance]]></article-title>
<source><![CDATA[Am Heart J]]></source>
<year>2004</year>
<volume>147</volume>
<page-range>218-23</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rebergen]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Chin]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Ottenkamp]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[van der Wall]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
<name>
<surname><![CDATA[de Roos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot: Volumetric quantitation by nuclear magnetic resonance velocity mapping]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>1993</year>
<volume>88</volume>
<page-range>2257-66</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oosterhof]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Mulder]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Vliegen]]></surname>
<given-names><![CDATA[HW]]></given-names>
</name>
<name>
<surname><![CDATA[de Roos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Cardiovascular magnetic resonance in the follow-up of patients with corrected tetralogy of Fallot: a review]]></article-title>
<source><![CDATA[Am Heart J]]></source>
<year>2006</year>
<volume>151</volume>
<page-range>265-72</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Therrien]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gatzoulis]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Graham]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Bink-Boelkens]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Connelly]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Niwa]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Canadian Cardiovascular Society Consensus Conference 2001 update: Recommendations for the management of adults with congenital heart disease-Part II.]]></article-title>
<source><![CDATA[Can J Cardiol]]></source>
<year>2001</year>
<volume>17</volume>
<page-range>1029-50</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kilner]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Pulmonary regurgitation in relation to pulmonary artery compliance and other variables]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Redington]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Van Arsdell]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
</person-group>
<source><![CDATA[Congenital heart diseases in the right heart]]></source>
<year>2009</year>
<page-range>247-50</page-range><publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Springer-Verlag]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ilbawi]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Idriss]]></surname>
<given-names><![CDATA[FS]]></given-names>
</name>
<name>
<surname><![CDATA[DeLeon]]></surname>
<given-names><![CDATA[SY]]></given-names>
</name>
<name>
<surname><![CDATA[Muster]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gidding]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Berry]]></surname>
<given-names><![CDATA[TE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Factors that exaggerate the deleterious effects of pulmonary insufficiency on the right ventricle after tetralogy repair: Surgical implications]]></article-title>
<source><![CDATA[J Thorac Cardiovasc Surg]]></source>
<year>1987</year>
<volume>93</volume>
<page-range>36-44</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kilner]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Pulmonary resistance in cardiovascular context]]></article-title>
<source><![CDATA[Int J Cardiol]]></source>
<year>2004</year>
<volume>97</volume>
<page-range>3-6</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abbas]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Fortuin]]></surname>
<given-names><![CDATA[FD]]></given-names>
</name>
<name>
<surname><![CDATA[Schiller]]></surname>
<given-names><![CDATA[NB]]></given-names>
</name>
<name>
<surname><![CDATA[Appleton]]></surname>
<given-names><![CDATA[CP]]></given-names>
</name>
<name>
<surname><![CDATA[Moreno]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Lester]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A simple method for noninvasive estimation of pulmonary vascular resistance]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2003</year>
<volume>41</volume>
<page-range>1021-7</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Okamoto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Miyatake]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kinoshita]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Sakakibara]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Nimura]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Analysis of blood flow in pulmonary hypertension with the pulsed Doppler flowmeter combined with cross-sectional echocardiography]]></article-title>
<source><![CDATA[Br Heart J]]></source>
<year>1984</year>
<volume>51</volume>
<page-range>407-15</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hirschfeld]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Meyer]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Schwartz]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Kofhagen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Kaplan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The echocardiographic assessment of pulmonary artery pressure and pulmonary vascular resistance]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>1975</year>
<volume>52</volume>
<page-range>642-50</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Matsuda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Sekiguchi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Sugishita]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Kuwako]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[K Iida]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ito]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Reliability of non-invasive estimates of pulmonary hypertension by pulsed Doppler echocardiography]]></article-title>
<source><![CDATA[Br Heart J]]></source>
<year>1986</year>
<volume>56</volume>
<page-range>158-64</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chan]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Currie]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Seward]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Hagler]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mair]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Tajik]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Comparison of three Doppler ultrasound methods in the prediction of pulmonary artery pressure]]></article-title>
<source><![CDATA[J Am Coll. Cardiol]]></source>
<year>1987</year>
<volume>9</volume>
<page-range>549-54</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murata]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Sonoda]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Morita]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Nakamura]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Takenaka]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Nagai]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The clinical significance of reversed flow in the main pulmonary artery detected by Doppler color flow imaging]]></article-title>
<source><![CDATA[Chest]]></source>
<year>2000</year>
<volume>118</volume>
<page-range>336-41</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Riggs]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Hirschfeld]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Borkat]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Knoke]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Liebman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Assessment of the pulmonary vascular bed by echocardiographic right ventricular systolic time intervals]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>1978</year>
<volume>57</volume>
<page-range>939-47</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scapellato]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Temporelli]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
<name>
<surname><![CDATA[Eleuteri]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Corrà]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
<name>
<surname><![CDATA[Imparato]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Giannuzzi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Accurate noninvasive estimation of pulmonary vascular resistance by Doppler echocardiography in patients with chronic failure heart failure]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2001</year>
<volume>37</volume>
<page-range>1813-9</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shandas]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Weinberg]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ivy]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Nicol]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[DeGroff]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
<name>
<surname><![CDATA[Hertzberg]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Development of a noninvasive ultrasound color M-mode means of estimating pulmonary vascular resistance in pediatric pulmonary hypertension: mathematical analysis, in vitro validation, and preliminary clinical studies]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2001</year>
<volume>104</volume>
<page-range>908-13</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tahara]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tanaka]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Nakao]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Yoshimura]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Sakurai]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tei]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Hemodynamic determinants of pulmonary valve motion during systole in experimental pulmonary hypertension]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>1981</year>
<volume>64</volume>
<page-range>1249-55</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ebeid]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrer]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
<name>
<surname><![CDATA[Robinson]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Weatherby]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Gelband]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Doppler echocardiographic evaluation of pulmonary vascular resistance in children with congenital heart disease]]></article-title>
<source><![CDATA[J Am Soc Echocardiogr]]></source>
<year>1996</year>
<volume>9</volume>
<page-range>822-31</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davlouros]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Niwa]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Webb]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gatzoulis]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The right ventricle in congenital heart disease]]></article-title>
<source><![CDATA[Heart]]></source>
<year>2006</year>
<volume>92</volume>
<page-range>i27-i38</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anavekar]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
<name>
<surname><![CDATA[Gerson]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Skali]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Kwong]]></surname>
<given-names><![CDATA[RY]]></given-names>
</name>
<name>
<surname><![CDATA[Yucel]]></surname>
<given-names><![CDATA[EK]]></given-names>
</name>
<name>
<surname><![CDATA[Solomon]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Two-dimensional assessment of right ventricular function: an Echocardiographic-MRI correlative study]]></article-title>
<source><![CDATA[Echocardiography]]></source>
<year>2007</year>
<volume>24</volume>
<page-range>452-6</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mor-Avi]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Badano]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
<name>
<surname><![CDATA[Belohlavek]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cardim]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Derumeaux]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE Consensus Statement on Methodology and Indications: Endorsed by the Japanese Society of Echocardiography]]></article-title>
<source><![CDATA[J Am Soc Echocardiogr]]></source>
<year>2011</year>
<volume>24</volume>
<page-range>277-313</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ueti]]></surname>
<given-names><![CDATA[OM]]></given-names>
</name>
<name>
<surname><![CDATA[Camargo]]></surname>
<given-names><![CDATA[EE]]></given-names>
</name>
<name>
<surname><![CDATA[Ueti Ade]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[de Lima-Filho]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Nogueira]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Assessment of right ventricular function with Doppler echocardiographic indices derived from tricuspid annular motion: comparison with radionuclide angiography]]></article-title>
<source><![CDATA[Heart]]></source>
<year>2002</year>
<volume>88</volume>
<page-range>244-8</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Forfia]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Fisher]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Mathai]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Housten-Harris]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Hemnes]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Borlaug]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tricuspid annular displacement predicts survival in pulmonary hypertension]]></article-title>
<source><![CDATA[Am J Respir Crit Care Med]]></source>
<year>2006</year>
<volume>174</volume>
<page-range>1034-41</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tei]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[New non-invasive index for combined systolic and diastolic ventricular function]]></article-title>
<source><![CDATA[J Cardiol]]></source>
<year>1995</year>
<volume>26</volume>
<page-range>135-36</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tei]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Dujardin]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[Hodge]]></surname>
<given-names><![CDATA[DO]]></given-names>
</name>
<name>
<surname><![CDATA[Bailey]]></surname>
<given-names><![CDATA[KR]]></given-names>
</name>
<name>
<surname><![CDATA[McGoon]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Tajik]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Doppler echocardiographic index for assessment of global right ventricular function]]></article-title>
<source><![CDATA[J Am Soc Echocardiogr]]></source>
<year>1996</year>
<volume>9</volume>
<page-range>838 - 46</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tei]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Nishimura]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Seward]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Tajik]]></surname>
<given-names><![CDATA[AJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Noninvasive Doppler-derived myocardial perfomance index: Correlation with simultaneous measurements of cardiac catheterization measurements]]></article-title>
<source><![CDATA[J Am Soc Echocardiogr]]></source>
<year>1997</year>
<volume>10</volume>
<page-range>169-78</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jurcut]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Giusca]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[La Gerche]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vasile]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ginghina]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Voigt]]></surname>
<given-names><![CDATA[J-U]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The echocardiographic assessment of the right ventricle: what to do in 2010?]]></article-title>
<source><![CDATA[Eur J Echocardiogr]]></source>
<year>2010</year>
<volume>11</volume>
<page-range>81-96</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rudski]]></surname>
<given-names><![CDATA[LG]]></given-names>
</name>
<name>
<surname><![CDATA[Lai]]></surname>
<given-names><![CDATA[WW]]></given-names>
</name>
<name>
<surname><![CDATA[Afilalo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hua]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Handschumacher]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Chandrasekaran]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Guidelines for the echocardiographic assesment of the right heart in adults: A report from the American Society of Echiocardiography. Endosed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography]]></article-title>
<source><![CDATA[J Am Soc Echocardiogr]]></source>
<year>2010</year>
<volume>23</volume>
<page-range>685-713</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ginés]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Grignola]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Sincronización de la contracción del ventrículo derecho frente a un aumento agudo de su postcarga. &ldquo;Izquierdización&rdquo; del comportamiento mecánico del ventrículo derecho]]></article-title>
<source><![CDATA[Rev Esp Cardiol]]></source>
<year>2001</year>
<volume>54</volume>
<page-range>973-80</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grignola]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Ginés]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Guzzo]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Comparison of the Tei index with invasive measurments of right ventricular function]]></article-title>
<source><![CDATA[Int J Cardiol]]></source>
<year>2006</year>
<volume>113</volume>
<page-range>25 - 33</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vogel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Schmidt]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Kristiansen]]></surname>
<given-names><![CDATA[SB]]></given-names>
</name>
<name>
<surname><![CDATA[Cheung]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[White]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Sorensen]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Validation of myocardial acceleration during Isovolumic contraction as a novel noninvasive index of right ventricular contractility comparison with ventricular pressure-volume relations in an animal model]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2002</year>
<volume>105</volume>
<page-range>1693-9</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haddad]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Hunt]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Rosenthal]]></surname>
<given-names><![CDATA[DN]]></given-names>
</name>
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Right ventricular function in cardiovascular disease, Part I: Anatomy, physiology, aging, and functional assessment of the right ventricle]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2008</year>
<volume>117</volume>
<page-range>1436-48</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[D&rsquo;Cruz]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Conventional and Color Doppler Assessment of Right-Sided Lesions]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Nanda]]></surname>
<given-names><![CDATA[NC]]></given-names>
</name>
</person-group>
<source><![CDATA[Doppler Echocardiograophy]]></source>
<year>1993</year>
<edition>2</edition>
<page-range>145-59</page-range><publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[London]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Li]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Davlouros]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Kilner]]></surname>
<given-names><![CDATA[PJ]]></given-names>
</name>
<name>
<surname><![CDATA[Pennell]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Gibson]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Henein]]></surname>
<given-names><![CDATA[MY]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Doppler-echocardiographic assessment of pulmonary regurgitation in adults with repaired tetralogy of Fallot: Comparison with cardiovascular magnetic resonance imaging]]></article-title>
<source><![CDATA[Am Heart J]]></source>
<year>2004</year>
<volume>147</volume>
<page-range>165-72</page-range></nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gatzoulis]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Cullen]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Newman]]></surname>
<given-names><![CDATA[CGH]]></given-names>
</name>
<name>
<surname><![CDATA[Redington]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Right Ventricular Diastolic Function 15 to 35 Years After Repair of Tetralogy of Fallot: Restrictive Physiology Predicts Superior Exercise Performance]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>1995</year>
<volume>91</volume>
<page-range>1775-81</page-range></nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carvalho]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Shinebourne]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Busst]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Rigby]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Redington]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Exercise capacity after complete repair of tetralogy of Fallot: deleterious effects of residual pulmonary regurgitation]]></article-title>
<source><![CDATA[Br Heart J]]></source>
<year>1992</year>
<volume>67</volume>
<page-range>470-3</page-range></nlm-citation>
</ref>
<ref id="B47">
<label>47</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Louie]]></surname>
<given-names><![CDATA[EK]]></given-names>
</name>
<name>
<surname><![CDATA[Rich]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Levitsky]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Brundage]]></surname>
<given-names><![CDATA[BH]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Doppler echocardiographic demonstration of the differential effects of right ventricular pressure and volume overload on left ventricular geometry and filling]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>1992</year>
<volume>19</volume>
<page-range>84-90</page-range></nlm-citation>
</ref>
<ref id="B48">
<label>48</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[King]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Braun]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Goldblatt]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Liberthson]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Weyman]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Interventricular septal configuration as a predictor of right ventricular systolic hypertension in children: a cross-sectional echocardiographic study]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>1983</year>
<volume>68</volume>
<page-range>68-75</page-range></nlm-citation>
</ref>
<ref id="B49">
<label>49</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guleserian]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Adult Congenital Heart Disease: Surgical advances and options]]></article-title>
<source><![CDATA[Prog Cardiovasc Dis]]></source>
<year>2011</year>
<volume>53</volume>
<page-range>254-264</page-range></nlm-citation>
</ref>
<ref id="B50">
<label>50</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stewart]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Backer]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mavroudis]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tetralogy of Fallot: Results of a pulmonary valve-sparing strategy]]></article-title>
<source><![CDATA[Ann Thorac Surg]]></source>
<year>2005</year>
<volume>80</volume>
<page-range>1431-1439</page-range></nlm-citation>
</ref>
<ref id="B51">
<label>51</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boni]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Galletti]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Current strategies in tetralogy of Fallot repair: pulmonary valve sparing and evolution of right ventricle/left ventricle pressures ratio]]></article-title>
<source><![CDATA[Eur J Cardiothorac Surg]]></source>
<year>2009</year>
<volume>35</volume>
<page-range>885-9</page-range></nlm-citation>
</ref>
<ref id="B52">
<label>52</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Valsangiacomo]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Hitendu]]></surname>
<given-names><![CDATA[HD]]></given-names>
</name>
<name>
<surname><![CDATA[Kellenberger]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Dodge-Khatami]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Petre]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Berger]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Remodelling of the right ventricle after early pulmonary valve replacement in children with repaired tetralogy of Fallot: assessment by cardiovascular magnetic resonance]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2005</year>
<volume>26</volume>
<page-range>2721-7</page-range></nlm-citation>
</ref>
<ref id="B53">
<label>53</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Therrien]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Provost]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Merchant]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Colman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Webb]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Optimal timing for pulmonary valve replacement in adults after tetralogy of Fallot repair]]></article-title>
<source><![CDATA[Am J Cardiol]]></source>
<year>2005</year>
<volume>95</volume>
<page-range>779-82</page-range></nlm-citation>
</ref>
<ref id="B54">
<label>54</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oosterhof]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[van Straten]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Vliegen]]></surname>
<given-names><![CDATA[HW]]></given-names>
</name>
<name>
<surname><![CDATA[Meijboom]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[van Dijk]]></surname>
<given-names><![CDATA[APJ]]></given-names>
</name>
<name>
<surname><![CDATA[Spijkerboer]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Preoperative thresholds for pulmonary valve replacement in patients with corrected Tetralogy of Fallot using cardiovascular magnetic resonance]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2007</year>
<volume>116</volume>
<page-range>545-51</page-range></nlm-citation>
</ref>
<ref id="B55">
<label>55</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Therrien]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Siu]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[McLaughlin]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[PP]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[WG]]></given-names>
</name>
<name>
<surname><![CDATA[Webb]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Pulmonary valve replacement in adults late after repair of tetralogy of Fallot: are we operating too late?]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2000</year>
<volume>36</volume>
<page-range>1670-5</page-range></nlm-citation>
</ref>
<ref id="B56">
<label>56</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harrison]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Harris]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Siu]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[MacLoghlin]]></surname>
<given-names><![CDATA[CJ]]></given-names>
</name>
<name>
<surname><![CDATA[Connelly]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Webb]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Sustained ventricular tachycardia in adult patients late after repair of tetralogy of Fallot]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>1997</year>
<volume>30</volume>
<page-range>1368 -73</page-range></nlm-citation>
</ref>
<ref id="B57">
<label>57</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harrison]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Siu]]></surname>
</name>
</person-group>
<source><![CDATA[]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B58">
<label>58</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Warnes]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Williams]]></surname>
<given-names><![CDATA[RG]]></given-names>
</name>
<name>
<surname><![CDATA[Bashore]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Child]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Connolly]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
<name>
<surname><![CDATA[Dearani]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease:: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons]]></article-title>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2008</year>
<volume>52</volume>
<page-range>e143 - e263</page-range></nlm-citation>
</ref>
<ref id="B59">
<label>59</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Baumgartner]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Bonhoeffer]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[De Groot]]></surname>
<given-names><![CDATA[NMS]]></given-names>
</name>
<name>
<surname><![CDATA[de Haan]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Deanfield]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Galie]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[ESC Guidelines for the management of grown-up congenital heart disease (new version 2010) The Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric Cardiology (AEPC)]]></article-title>
<source><![CDATA[Eur Heart J]]></source>
<year>2010</year>
<volume>31</volume>
<page-range>2915-57</page-range></nlm-citation>
</ref>
<ref id="B60">
<label>60</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cheung]]></surname>
<given-names><![CDATA[EW]]></given-names>
</name>
<name>
<surname><![CDATA[Wong]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
<name>
<surname><![CDATA[Cheung]]></surname>
<given-names><![CDATA[YF]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Meta-analysis of pulmonary valve replacement after operative repair of Tetralogy of Fallot]]></article-title>
<source><![CDATA[Am J Cardiol]]></source>
<year>2010</year>
<volume>106</volume>
<page-range>552-7</page-range></nlm-citation>
</ref>
<ref id="B61">
<label>61</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Martucci]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Therrien]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Timing and outcome of surgical pulmonary valve replacement]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Redington]]></surname>
<given-names><![CDATA[AN]]></given-names>
</name>
<name>
<surname><![CDATA[Van Arsdell]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
</person-group>
<source><![CDATA[Congenital diseases in right heart]]></source>
<year></year>
<page-range>2009:259</page-range><publisher-loc><![CDATA[London ]]></publisher-loc>
<publisher-name><![CDATA[Springer-Verlag]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B62">
<label>62</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Siwik]]></surname>
<given-names><![CDATA[ES]]></given-names>
</name>
<name>
<surname><![CDATA[Erenberg]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Zahka]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
<name>
<surname><![CDATA[Goldmuntz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tetralogy of Fallot]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Allen]]></surname>
<given-names><![CDATA[HD]]></given-names>
</name>
<name>
<surname><![CDATA[Driscoll]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Shaddy]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Feltes]]></surname>
<given-names><![CDATA[TF]]></given-names>
</name>
</person-group>
<source><![CDATA[Moss and Adams&rsquo; heart disease in infants, children, and adolescents: Including the fetus and young adults]]></source>
<year></year>
<edition>7</edition>
<publisher-loc><![CDATA[Philadelphia (USA) ]]></publisher-loc>
<publisher-name><![CDATA[Lippincott Williams and Wilkins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B63">
<label>63</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoffman]]></surname>
<given-names><![CDATA[JIE]]></given-names>
</name>
</person-group>
<source><![CDATA[The natural and unnatural history of congenital heart disease: Chennai (India)]]></source>
<year>2009</year>
<page-range>412</page-range><publisher-name><![CDATA[John Wiley and Sons Ltd]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B64">
<label>64</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Faidutti]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Christenson]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[Beghetti]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Friedli]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Kalangos]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[How to diminish reoperation rates after initial repair of tetralogy of Fallot?]]></article-title>
<source><![CDATA[Ann Thorac Surg]]></source>
<year>2002</year>
<volume>73</volume>
<page-range>96-101</page-range></nlm-citation>
</ref>
<ref id="B65">
<label>65</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Herman]]></surname>
<given-names><![CDATA[SG]]></given-names>
</name>
<name>
<surname><![CDATA[Baselga]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Parnas Fernandez]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alvarez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Soto]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="es"><![CDATA[Evolución de los pacientes con tetralogía de Fallot. Hospital del Niño Jesús de San Miguel de Tucumán: Análisis de la base de datos]]></article-title>
<source><![CDATA[Rev Fed Arg Cardiol]]></source>
<year>2007</year>
<volume>36</volume>
<page-range>87-93</page-range></nlm-citation>
</ref>
<ref id="B66">
<label>66</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[d&rsquo;Udekem]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Ovaert]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Grandjean]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Gerin]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Cailteux]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Shango-Lody]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tetralogy of Fallot]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2000</year>
<volume>102</volume>
<numero>^s19</numero>
<issue>^s19</issue>
<supplement>19</supplement>
<page-range>III116-22</page-range></nlm-citation>
</ref>
<ref id="B67">
<label>67</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alexiou]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Galogavrou]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gnanapragasam]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Salmon]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Keeton]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Repair of tetralogy of Fallot in infancy with a transventricular or a transatrial approach]]></article-title>
<source><![CDATA[Eur J Cardiothorac Surg]]></source>
<year>2002</year>
<volume>22</volume>
<page-range>174-83</page-range></nlm-citation>
</ref>
<ref id="B68">
<label>68</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fuster]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[McGoon]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Ritter]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Kirklin]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Long-term evaluation (12 to 22 years) of open heart surgery for tetralogy of Fallot]]></article-title>
<source><![CDATA[Am J Cardiol]]></source>
<year>1980</year>
<volume>46</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>635-42</page-range></nlm-citation>
</ref>
<ref id="B69">
<label>69</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bacha]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Scheule]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Zurakowski]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Erickson]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
<name>
<surname><![CDATA[Hung]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Long-term results after early primary repair of tetralogy of Fallot]]></article-title>
<source><![CDATA[J Thorac Cardiovasc Surg]]></source>
<year>2001</year>
<volume>122</volume>
<page-range>154-161</page-range></nlm-citation>
</ref>
<ref id="B70">
<label>70</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murphy]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Gersh]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Mair]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Fuster]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[McGoon]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
<name>
<surname><![CDATA[Ilstrup]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Long-term outcome in patients undergoing surgical repair of tetralogy of Fallot]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>1993</year>
<volume>329</volume>
<page-range>593-9</page-range></nlm-citation>
</ref>
<ref id="B71">
<label>71</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fuster]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[McGoon]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Kennedy]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Ritter]]></surname>
<given-names><![CDATA[DG]]></given-names>
</name>
<name>
<surname><![CDATA[Kirklin]]></surname>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Long-term evaluation (12 to 22 years) of open heart surgery for tetralogy of Fallot]]></article-title>
<source><![CDATA[Am.J. Cardiol]]></source>
<year>1980</year>
<volume>46</volume>
<page-range>635 642</page-range></nlm-citation>
</ref>
<ref id="B72">
<label>72</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yuman]]></surname>
</name>
<name>
<surname><![CDATA[Ge]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Xie]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Right ventricular global longitudinal systolic and diastolic function is diminished in patientswWith pulmonary arterial hypertension: A 2D ultrasound speckle tracking imaging (Abstract)]]></article-title>
<source><![CDATA[Circulation]]></source>
<year>2009</year>
<volume>120</volume>
<page-range>s387</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
